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ABSTRACT 
English 
Pneumolysin, a protein toxin, represents one of the major virulence factors of 
Streptococcus pneumoniae. This pathogen causes bacterial meningitis with especially high 
disease rates in young children, elderly people and immunosuppressed patients. The 
protein toxin belongs to the family of cholesterol-dependent cytolysins, which require 
membrane cholesterol in order to bind and to be activated. Upon activation, monomers 
assemble in a circle and undergo conformational change. This conformational change 
leads to the formation of a pore, which eventually leads to cell lysis. This knowledge was 
obtained by studies that used a higher concentration compared to the concentration of 
pneumolysin found in the cerebrospinal fluid of meningitis patients. Thus, a much lower 
concentration of pneumolysin was used in this work in order to investigate effects of this 
toxin on primary mouse astrocytes. Previously, a small GTPase activation, possibly leading 
to cytoskeletal changes, was found in a human neuroblastoma cell line. This led to the 
hypothesis that pneumolysin can lead to similar cytoskeletal changes in primary cells. The 
aim of this work was to investigate and characterise the effects of pneumolysin on 
primary mouse astrocytes in terms of a possible pore formation, cellular trafficking and 
immunological responses. Firstly, the importance of pore-formation on cytoskeletal 
changes was to be investigated. In order to tackle this question, wild-type pneumolysin 
and two mutant variants were used. One variant was generated by exchanging one amino 
acid in the cholesterol recognising region, the second variant was generated by deleting 
two amino acids in a protein domain that is essential for oligomerisation. These variants 
should be incapable of forming a pore and were compared to the wild-type in terms of 
lytic capacities, membrane binding, membrane depolarisation, pore-formation in artificial 
membranes (planar lipid bilayer) and effects on the cytoskeleton. These investigations 
resulted in the finding that the pore-formation is required for inducing cell lysis, 
membrane depolarisation and cytoskeletal changes in astrocytes. The variants were not 
able to form a pore in planar lipid bilayer and did not cause cell lysis and membrane 
depolarisation. However, they bound to the cell membrane to the same extent as the 
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wild-type toxin. Thus, the pore-formation, but not the membrane binding was the cause 
for these changes.  
Secondly, the effect of pneumolysin on cellular trafficking was investigated. Here, 
the variants showed no effect, but the wild-type led to an increase in overall endocytotic 
events and was itself internalised into the cell. In order to characterise a possible 
mechanism for internalisation, a GFP-tagged version of pneumolysin was used. Several 
fluorescence-labelled markers for different endocytotic pathways were used in a co-
staining approach with pneumolysin. Furthermore, inhibitors for two key-players in 
classical endocytotic pathways, dynamin and myosin II, were used in order to investigate 
classical endocytotic pathways and their possible involvement in toxin internalisation. The 
second finding of this work is that pneumolysin is taken up into the cell via dynamin- and 
caveolin-independent pinocytosis, which could transfer the toxin to caveosomes. From 
there, the fate of the toxin remains unknown. Additionally, pneumolysin leads to an 
overall increase in endocytotic events.  
This observation led to the third aim of this work. If the toxin increases the overall 
rate of endocytosis, the question arises whether toxin internalisation favours bacterial 
tissue penetration of the host or whether it serves as a defence mechanism of the cell in 
order to degrade the protein. Thus, several proinflammatory cytokines were investigated, 
as previous studies describe an effect of pneumolysin on cytokine production. 
Surprisingly, only interleukin 6-production was increased after toxin-treatment and no 
effect of endocytotic inhibitors on the interleukin 6-production was observed. The 
conclusion from this finding is that pneumolysin leads to an increase of interleukin 6, 
which would not depend on the endocytotic uptake of pneumolysin. The production of 
interleukin 6 would enhance the production of acute phase proteins, T-cell activation, 
growth and differentiation. On the one hand, this activation could serve pathogen 
clearance from infected tissue. On the other hand, the production of interleukin 6 could 
promote a further penetration of pathogen into host tissue. This question should be 
further investigated. 
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Deutsch 
Das Protein-Toxin Pneumolysin ist einer der entscheidenden Virulenzfaktoren von 
Streptococcus pneumoniae. Dieser Erreger verursacht bakterielle Meningitis, die vor allem 
Kleinkinder, ältere Menschen und immungeschwächte Patienten betrifft. Dieses Protein-
Toxin gehört zur Familie der cholesterinabhängigen Zytolysine, die Membrancholesterol 
für ihre Aktivierung und Bindung benötigen. Nach der Membranbindung ordnen sich die 
Toxinmonomere kreisförmig an und ändern ihre Konformation, wodurch eine Pore 
entsteht, die dann zu einer Lyse der Zelle führt. Studien, die diese Erkenntnisse brachten, 
nutzen eine höhere Konzentration des Toxins, als in der zerebrospinalen Flüssigkeit von 
Meningitispatienten gefunden wurde. Aus diesem Grund wurde in vorliegender Arbeit 
genau diese Konzentration von Pneumolysin genutzt, um die Effekte dieses Toxins auf 
primäre Mausastrozyten zu untersuchen. Vor kurzem wurde nach 
Pneumolysinbehandlung in einer humanen Neuroblastomzelllinie eine Aktivierung kleiner 
GTPasen gefunden, die für zytoskelettale Veränderungen entscheidend sind (z.B. 
Zellbewegungen). Deshalb wurde die Hypothese aufgestellt, dass Pneumolysin diese 
zytoskelettalen Veränderungen auch in primären neuronalen Zellen auslösen könnte.  
Das Ziel dieser Arbeit war, die Effekte von Pneumolysin auf primäre Mausastrozyten 
im Hinblick auf Porenbildung, zelluläre Transportprozesse und immunologische 
Antworten zu untersuchen. Im ersten Teil wird die Bedeutung der Porenbildung auf 
zytoskelettale Veränderungen untersucht. Hierfür wurden der Wildtyp und zwei 
Varianten des Pneumolysin genutzt. Die erste Variante wurde hergestellt, indem ein 
Aminosäureaustausch in einem Proteinbereich hergestellt wurde, der für die 
Membrancholesterolerkennung durch das Toxin entscheidend ist. Die zweite Variante 
wurde hergestellt, indem zwei Aminosäuren in der Proteinregion deletiert wurden, die 
entscheidend für die Oligomerisierung der Monomere ist. Diese beiden 
Pneumolysinvarianten sollten also nicht in der Lage sein eine Pore in der Zellmembran zu 
bilden und wurden mit dem Wildtyp verglichen. Hierbei wurden lytische Fähigkeiten, 
Membranbindung, Membrandepolarisation, Porenbildung im künstlichen Bilayer und 
Effekte auf das Zytoskelett untersucht. Sowohl der Wildtyp als auch die Varianten zeigten 
die gleiche Stärke an Membranbindung. Diese Untersuchungen weisen darauf hin, dass 
die Porenbildung für die Zell-Lyse, Membrandepolarisation und zytoskelettale 
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Veränderungen in Mausastrozyten wichtig ist und führt zu der Schlussfolgerung, dass 
nicht die Membranbindung, sondern die Porenbildung entscheidend für die beobachteten 
zytoskelettalen Veränderungen ist.  
Im zweiten Teil dieser Arbeit wurde der Effekt des Pneumolysin auf zelluläre 
Transportprozesse untersucht. Erneut zeigten die Pneumolysinvarianten keine Wirkung, 
während der Wildtyp die Gesamtrate der Endozytose erhöhte. Weiterhin wurde nur der 
Wildtyp internalisiert. Um einen möglichen Mechanismus für die Internalisierung des 
Toxins vorschlagen zu können, wurde Pneumolysin als GFP-markiertes Toxin genutzt. 
Weiterhin wurden einige Marker für unterschiedliche endozytotische Transportprozesse 
genutzt um eine Ko-lokalisation mit Pneumolysin-GFP zu ermöglichen. Des Weiteren 
wurden Inhibitoren für zwei Schlüsselproteine endozytotischer Vorgänge, Dynamin und 
Myosin II, genutzt. Die Ergebnisse dieser Untersuchungen zeigten, dass Pneumolysin 
wahrscheinlich durch dynamin- und caveolin-unabhängige Pinozytose in die Zelle 
aufgenommen wird. Dieser Mechanismus führt zu der Bildung von Caveosomen, deren 
weiterer Transport, und somit das Schicksal des internalisierten Toxins, bis heute noch 
nicht aufgeklärt ist.  
Die Beobachtung, dass Pneumolysin die Gesamtrate an Endozytose erhöht, führte 
zum dritten Teil dieser Arbeit. Wenn das Toxin die Gesamtrate an Endozytose erhöht, 
stellt sich die Frage, ob dieser Vorgang der Zerstörung des Toxins – also einer Abwehr der 
Zelle – dient, oder ob diese Internalisierung eine Strategie des Pathogens ist, um tiefer in 
das Wirtsgewebe einzudringen. Aktuelle Studien belegen, dass Pneumolysin einen 
Einfluss auf inflammatorische Antworten des Immunsystems hat. Aus diesem Grund 
wurden unterschiedliche proinflammatorische Zytokine untersucht. Überraschenderweise 
zeigte sich nur eine Erhöhung des Interleukin 6 nach der Toxinbehandlung. Weiterhin 
hatten die Endozytoseinhibitoren keinen Effekt auf die Produktion dieses 
proinflammatorischen Zytokins. Pneumolysin führt also zu einem Anstieg der Interleukin 
6 Produktion, diese Produktion ist jedoch unabhängig von der Internalisierung dieses 
Toxins. Die Produktion dieses Interleukins würde zur Produktion der Akute-Phase 
Proteine, der Aktivierung der T-Zell Antwort, zu Wachstum und Zelldifferenzierung 
führen. Einerseits könnte diese Aktivierung die Infektion durch das Pathogen bekämpfen. 
Andererseits könnte S. pneumoniae die erhöhte Produktion durch PLY an Interleukin 6 
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nutzen um weiter in das Wirtsgewebe vordringen zu können. Diese Frage sollte noch 
durch weitere Experimente untersucht werden. 
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1 INTRODUCTION 
1.1 Pneumococcal meningitis 
The meninges are responsible for the protection of the central nervous system 
(CNS) from infections (Kim 2010). In bacterial meningitis these are infected. The meninges 
consist of three connective tissue membranes: pia mater, arachnoid mater and dura 
mater. The pia is a very thin membrane, which is closest to the brain and even covers 
small invaginations of the brain. The arachnoid, meaning “spider like”, is a web-like 
structure and similar to the pia concerning the regions which it covers. The dura is a hard 
inelastic covering that is close to the inner surface of the skull (Squire and Zigmond 2003). 
 
 
 
Fig 1:  The meninges of the brain. Modified from Kristensson (Kristensson 2011). Visible are the three 
meninges surrounding the brain under the skull. The dura mater being the outermost and hardest meninges 
located directly under the skull. The arachnoid, representing the meninges under the dura mater and the 
pia mater, being the softest and thinnest meninges being closest to the brain. 
 
The infection of the meninges has critical effects on the brain, such as remaining 
neurological sequelae e.g. as cognitive deficits and behavioural problems (Ortqvist, 
Hedlund et al. 2005; Herrmann, Kellert et al. 2006). If this barrier is damaged, for example 
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after surgical treatments or infection, pathogens could enter into the brain in an invasive 
manner and reach regions that otherwise would be well protected.  
According to the World Health Organisation (WHO) bacterial meningitis represents 
the most-feared infectious disease in children (O'Brien, Wolfson et al. 2009). Neisseria 
meningitidis, Haemophilus influenza and Streptococcus pneumonia are the most common 
causes of bacterial meningitis (Hart, Cuevas et al. 1993; Ciana, Parmar et al. 1995). Here, 
S. pneumonia and H. influenzae represent the leading cause of death in young children in 
the developing countries.  
 
 
Fig 2: Overview of occurences of bacterial meningitis worldwide from O’Brien and Wolfson et al. (O'Brien, 
Wolfson et al. 2009). The map shows pneumococcal deaths in children at the age of 1-59 month per 100 
000 children. It has to be noted that HIV-positive children are excluded. The high incidence in developing 
countries becomes clear. 
 
In 1999 the WHO estimated that five million neonatal deaths occur per year (Lazo, 
Tamura et al. 2001). The high prevalence in infants and the focus on developing countries 
can be explained by the following risk factors: low birth weight, low socioeconomic status 
of the mother and prematurity (Lazo, Tamura et al. 2001). Nevertheless, precise studies 
are almost impossible, as a tight monitoring of meningitis is difficult to be carried out in 
those countries. In his review Furyk describes the following statistics: 14 out of 23 studies 
on neonatal meningitis were performed in Africa, three were a multicentre study carried 
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out by the WHO, four were from the Middle East, two were carried out in Latin America 
and in Asia. All these studies were carried out under different conditions leading to a 
difficult comparability until today (Furyk, Swann et al. 2011).  
S. pneumonia causes the most common form of bacterial meningitis (Ortqvist, 
Hedlund et al. 2005) and causes diseases such as otitis media and pneumonia (Kadioglu, 
Weiser et al. 2008). Disease rates are very high in young children, elderly people and 
immunosuppressed patients (Ortqvist, Hedlund et al. 2005). Majorily, developing 
countries are affected (Lazo, Tamura et al. 2001.). After infection with bacterial 
meningitis, 15-20% of patients survive with neurological sequelae such as hearing loss, 
seizures and mental retardation (Baraff, Lee et al. 1993; Ciana, Parmar et al. 1995; Qazi, 
Khan et al. 1996). These sequelae could be explained by the brain regions that are 
damaged, for example the the hippocampal formation, where also neural stem cells can 
be found that might serve a stimulation of neuronal outgrowth after damage of that 
region (Zhang and Barres 2010). Coverage of vaccination and antibiotic treatment turn 
out to be difficult, as S. pneumonia shows 90 (or more) serotypes and pneumococci show 
a reduced susceptibility to penicillin (Ortqvist, Hedlund et al. 2005). Nevertheless, S. 
pneumonia infection not only represents a threat to developing countries but also to 
highly developed ones as well (Jedrzejas 2001). 
In developed countries S. pneumoniae is the most common pathogen causing 
meningitis in adults (Kastenbauer and Pfister 2003). Here again infection mostly occurs 
after invasive surgical procedures. Bacterial meningitis occurs much more often in infants 
(Kim 2010). In developed countries the case fatality rates (CFR) for bacterial meningitis lie 
in the range of 4.5% and at 15-50 % in developing countries (O'Brien, Wolfson et al. 
2009). The mortality rate caused by S. pneumonia lies at 40.000 per year in the USA and is 
thus larger than the mortality rate caused by any other bacterial pathogen (Jedrzejas 
2001). So, understanding mechanisms of this disease in order to develop ideas for 
possible cures is a tempting task. 
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1.2 Cell types in the brain and their function 
As an infection of the meninges can spread further into the brain, it is important to 
understand the effect of the infection on the brain and on brain cells. In the brain nerve 
cells and their extensions, dendrites and axons are closely surrounded by glial cells. For 
maintenance of learning and memory a proper functioning of neurons in the brain is 
required. This functioning and the homeostasis in the brain depend on functional glial 
cells including astrocytes, oligodenrocytes and microglia. 
 
1.2.1 Neurons  
The neuron cannot be defined into only one phenotypical form. Textbook 
knowledge states that the neuron is a highly polarised cell, which in its development 
forms distinct cellular domains. In general, a neuron consists of a cell body, the 
perykaryon, which contains the nucleus and the major cytoplasmatic organelles, which 
produce all proteins and membranes of the neuron. From this perikaryon several 
dendrites emanate, varying in size and shape. Thirdly, an axon emerges from the 
perikaryon. The axon extends farther from the cell body than the dendrites (Squire and 
Zigmond 2003). The Axon is a structure required for the transmission of actionpotentials. 
At the cell soma dendrites are found which can also represent the postsynapse. 
Generally, neurons are assembled by the same components compared to any other cell 
type. Nevertheless, neurons show diverse phenotypes (Fig 3). Four major classifications 
can be named: interneurons, sensory neurons, motor neurons and pyramidal cells. 
Interneurons, which show a bipolar phenotype, are composed of a branched axon and 
serve the interconnection between other neurons. The dendrites of interneurons show a 
non-spiny phenotype (Squire and Zigmond 2003). Sensory neurons convert external 
stimuli into internal stimuli, meaning that they send information to the brain. 
Motoneurons, in contrast, convert internal signals and send those to muscles. Pyramidal 
cells facilitate the development of neuronal circuits within the brain. Here, a spiny 
phenotype of dendrites can be found (Squire and Zigmond 2003). 
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Fig 3: Basic neuron types. Modified from Kuffler and Martin et al. (Kuffler, Martin et al. 1984). Roughly, 
four basic neuron types can be described. Mostly, interneurons show a bipolar phenotype. Sensory neurons 
show an unipolar phenotype. Motoneurons show a multipolar phenotype and pyramidal cells a highly 
branched phenotype. 
 
Neurons can have excitatory, inhibitory or modulatory functions. Again, the role of 
a neuron can be found by looking at the cellular phenotype of these cells. Assymetric 
synapses are responsible for the transmission of excitatory inputs, whereas symmetric 
synapses are responsible for an inhibitory transmission. Furthermore, these functions are 
mastered by the use of neurotransmitters. The main excitatory neurons in the cerebral 
cortex are pyramidal cells and the excitatory neurotransmitters found here are glutamate 
and possibly aspartate (Squire and Zigmond 2003).  
Most neurotransmitters, acetylcholin being the only exception, are amino acids, 
derivates from amino acids, nucleotides and ATP. Classically, one neuron only produces 
one neurotransmitter. These exit the cell via exocytosis into the synaptic cleft. The next 
neuron, on the other side of the synaptic cleft, usually produces the receptors for those 
neurotransmitters. Some neurons also release neuropeptides into the synaptic cleft. 
Nevertheless, those are stored in different vesicles. Neuropeptides establish their 
signalling over a longer period of time (up to days) compared to neurotransmitters 
(Siegel, Albers et al. 2006). 
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1.2.2 Glia 
The major population of cells found in the brain are glial cells. Rudolf Virchow gave 
these cells their name in 1859, as he found neuroglia as a tissue that held neurons 
together functioning as a connective tissue (Squire and Zigmond 2003). They make up half 
of the volume of the human brain (Barres 2008). Ramón y Cajal and del Rio-Hortega 
managed to classify neuroglial types phenotypically into three types: oligodendrocytes, 
astrocytes and microglia (Squire and Zigmond 2003). Here, microglia and astrocytes will 
be discussed in further detail.  
 
1.2.2.1 Microglia 
For a long time, the brain has been seen as an immunological compromised site 
(Squire and Zigmond 2003). However, microglia represent macrophage-like cells and thus 
immune cells in the brain and make up about 10% of CNS glial cells (Barres 2008). One of 
the hallmarks of microglia is that they can become reactive and respond to pathological 
challenges (Squire and Zigmond 2003). At the point of infection they can follow a 
chemotactic gradient and reach the site of insult in the tissue. They are evenly dispersed 
throughout the brain and are highly motile. Thus, they have the capacity to move, 
proliferate and phagocytose (Kettenmann, Hanisch et al. 2011). Microglia may secrete 
cytokines or growth factors (Block, Zecca et al. 2007). They are found in all regions of the 
brain. They have small rod shaped somas from which many processes emanate. Cell-cell 
contacts, however, have not been described so far (Squire and Zigmond 2003).  
 
1.2.2.2 Astrocytes 
The name of astrocytes is based on the Greek word for star giving a hint at the 
shape, namely a star-like cell shape. Nevertheless, astroglia show many phenotypes. 
Markers for immunocytochemical staining are the glial fibrillary acidic protein (GFAP), S-
100, which is a calcium-binding protein, and glutamine synthetase (Squire and Zigmond 
2003). Especially Astrocytes play an essential role in the maintenance of neuronal 
functions. They surround or “fence in” neurons by extending long processes which range 
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to the pia mater (Squire and Zigmond 2003). Astrocytes regulate the recycling of 
neurotransmitters and play an essential role in repair of injury of neurons (Barreto, 
Gonzalez et al. 2011). If neurotranmsmitters stay in the synaptic cleft, new signalling 
could be disturbed. Thus, astrocytes take up neurotransmitters for a clearance of the 
synaptic cleft (Squire and Zigmond 2003). Furthermore, astrocytes play an important role 
in neural development. They can either represent stem cells that become neurons, they 
can promote neurite outgrowth, guide axon projections and much more (Barres 2008; 
Zhang and Barres 2010). 
Astrocytes are interconnected by gap junctions, which enable those cells to 
exchange ions and small molecules (Squire and Zigmond 2003).  
In the case of neuronal damage the astrocyte responds with a reactive gliosis. 
Initially this process turns out to be neuroprotective (Barreto, Gonzalez et al. 2011). On 
the other hand, the reaction of the astrocyte can cause damage to the neurons by 
producing a toxic edema leading to neuroinflammatory processes (Barreto, Gonzalez et 
al. 2011).  
 
Fig 4: Reactive astrocytes in brain injury. Modified from Barreto and Gonzalez et al. (Barreto, Gonzalez et 
al. 2011). Astrocytes can produce neurotransmitters, cytokines, growth factors and antioxidants upon 
activation. 
 
Astrocytes are known to release and recycle neurotransmitters essential for 
neurons. Upon brain damage, glutamate receptors in astrocytes can decrease in number 
leading to an excitotoxic effect on the neurons (Barreto, Gonzalez et al. 2011). On the 
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other hand, astrocytes downregulate glutamate production after brain injury and thus 
decrease excitotoxicity (Zou, Wang et al. 2010). For a long time it was believed that 
astrocytes physically form the blood brain barrier (BBB), but now it is known, that 
astrocytes form and maintain the tight junctions in endothelial cells, that form the BBB. 
Astrocytes also play a role in migration and guidance of neurons in early brain 
development, by producing for example growth factors (Squire and Zigmond 2003). 
 
1.2.3 Maintenance of the blood brain barrier 
The blood brain barrier (BBB) consists of an epithelial cell layer that is surrounded 
by astrocytes (Kristensson 2011). This layer protects the CNS from a non-selective passage 
of molecules and toxins, while metabolites are able to pass (Kristensson 2011). The BBB 
consist of four cellular elements: endothelial cells (ECs), astrocytes end-feet, microglial 
cells and pericytes. In some regions of the CNS, the BBB is replaced by cerebrospinal fluid 
(CSF) (Correale and Villa 2009).  
 
Fig 5: The Blood Brain Barrier. From Abbott and Ronnback et al. (Abbott, Ronnback et al. 2006). The 
different mechanisms are visible that facilitate transport of nutrients across the blood brain barrier. 
Possible mechanisms are the paracellular aqueous pathway, the transcellular lipophilic pathway, transport 
via transport proteins, receptor mediated transcytosis and adsorptive transcytosis. 
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As depicted in Fig 5 small water-soluble agents can pass the endothelial layer 
through gap-junctions whereas lipid-soluble agents can diffuse through endothelial cells. 
Transport proteins are moved across the BBB via active transport through receptors. 
Other proteins pass the BBB via receptor-mediated or adsorptive-transcytosis (Abbott, 
Ronnback et al. 2006), which will be explained in a later chapter. The BBB is disrupted in 
the course of bacterial meningitis. This is due to the fact, that meningeal vessels are more 
permeable than vessels in the brain parenchyma, which will eventually lead to a passage 
of pathogens across the BBB (Kristensson 2011). The exact mechanism used by 
S. pneumoniae is not yet clarified (Mook-Kanamori, Geldhoff et al. 2011). One way used 
to cross the BBB could be the binding of pneumococcal phosphorylcholine to the platlet 
activating factor (PAF) and thus leading to transcytosis entering the PAF-receptory cycling 
pathway. Other possibilities are utilising the IgG recycling pathway or the release of 
reactive oxygen species (ROS) leading to tissue damage, that increases the permeability of 
the BBB (Mook-Kanamori, Geldhoff et al. 2011). Nevertheless, the invasive strategy of 
S. pneumoniae is shown by the increase of proinflammatory cytokines in hippocampal 
and cortical tissue of young rats after infection with S. pneumonia shown by the 
distribution of evans blue into the brain 12-24 h after infection (Barichello, Pereira et al. 
2011). 
 
1.2.4 Cytoskeleton of cells in the brain 
The cytoskeleton is composed of the actin-cytoskeleton, microtubili and 
intermediate filaments. These components enable the cell to move and to adhere 
(Alberts 2008). In addition, the cytoskeletal components provide a structural organisation 
for the cell e.g. by allowing a separation into different intracellular compartments. 
Furthermore, they serve as tracks for intracellular transport-mechanisms (Siegel, Albers et 
al. 2006). In terms of cellular movement the cell requires a remodelling of the actin 
cytoskeleton.  In order to migrate, the cell extends a lammellipodium at the front of the 
cell. This process is followed by the contraction of the cell body and by the loosening of 
the tail adherence (Ridley 2001). This process involves actin polymerisation which is 
possible due to the signalling of Rho GTPases, such as Rho, Rac1 and CDC42 (Ridley 2001).  
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Fig 6: Function of Rho GTPases in cellular movement. Modified from Ridley (Ridley 2001). Upon 
stimulation, the cell forms lammellipodia at the front of the cell. The cell body contracts, facilitated by the 
formation of stress-fibres, and the tail of the cell retracts. This provides directionality to the movement of 
the cell. 
 
 
The small GTPases Rho and Rac lead to the downstream regulation of many 
proteins involved in actin polymerization e.g. Arp2/3 or depolymerisation e.g. cofilin. The 
activity of the small GTPases depends on their state of GTP/ GDP-binding. The exchange 
of GDP to GTP is enabled by guanine nucleotide exchange factors (GEFs), which eventually 
leads to an activation of the small GTPase. An inactivation is enabled by GTPase activating 
proteins (GAPs), which catalyse a GTP hydrolysis. In an activated state the small GTPases 
bind to their downstream targets, in the case of Rho to ROCK (Rho associated serin- 
threonine kinase) and in the case of Rac to PAK (p21-activated kinase). ROCK and PAK can 
then activate LIMKs, which are essential for the regulation of Cofilins (Ridley 2006).  
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Fig 7: Functions of small GTPases modified from Ridley (Ridley 2006). Small GTPases facilitate a regulation 
of cytoskeletal processes such as actin polymerisation and depolymerisation. These functions are supported 
and mediated by GEFs and GAPs. 
 
Via these highly regulated mechanisms the cell preserves the capability to react to 
external stress and to move away from stressors or towards chemotactic gradient.  
Previously, it has been shown that bacteria have evolved different strategies to modulate 
the actin cytoskeleton by their toxins (Aspenstrom 1999; Aktories and Barbieri 2005). For 
pneumolysin it has been shown, that it activates RhoA and Rac1 GTPases and thus leads 
to a formation of filopodia, lammelipodia and stress fibers in a human neuroblastoma cell 
line (Iliev, Djannatian et al. 2007). The question remains to what extent the toxin achieves 
these modulations and what the biological significance of these changes is. 
 
1.3 The family of the cholesterol dependent cytolysins 
Cholesterol dependent cytolysins (CDCs) represent a family of protein toxins, which 
require membrane cholesterol in order to bind and to be activated (Solovyova, Nollmann 
et al. 2004; Tweten 2005). These toxins are produced by Gram positive bacteria such as 
C. perfringens, S. intermedius, L. monocytogenes and S. pneumoniae. CDCs bind to 
membrane cholesterol, oligomerise in a pre-pore and, after undergoing conformational 
change, punch a huge pore into the membrane of the cell leading to cell lysis (Alouf 2000; 
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Aktories and Barbieri 2005). The members of this family show a significant amino acid 
identity and similarity. Most structural studies and crystal structures have been obtained 
on perfringolysin O (PFO) from C. perfingens and intermediolysin (ILY) from S. intermedius 
(Rosado, Buckle et al. 2007). Rossjohn et al. solved the structure of perfingolysin O 
(Rossjohn, Polekhina et al. 2007). This structure serves as a suggestion for the structure of 
other CDCs based on the assumption that they might share a high structural similarity. 
 
Fig 8: Struture of perfringolysin O as a structural suggestion for PLY. Modified from Rossjohn and Polekhina 
et al. (Rossjohn, Polekhina et al. 2007). PLY consists of four domains showing a slightly curved, but not 
globular shape.  
 
1.3.1 Pneumolysin 
Pneumolysin (PLY) is a major virulence determinant for S. pneumoniae and also 
shows many effects on host immune components at sub-lytic concentrations (Kadioglu, 
Weiser et al. 2008). It plays a distinct role in the early pathogenesis of infection (Ortqvist, 
Hedlund et al. 2005). PLY belongs to the family CDCs, meaning that the toxin preferably 
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forms pores in cholesterol-rich regions of the plasma membrane (Marriott, Mitchell et al. 
2008) and has the capability to bind cholesterol (Jedrzejas 2001). Pneumolysin is 
produced by virtually all clinical isolates of S. pneumoniae (Kanclerski and Mollby 1987). 
PLY is a cytosolic protein, released predominantly upon bacterial auto-lysis (Berry, Yother 
et al. 1989), although other mechanisms are also suggested e.g. via a secretion 
mechanism (Balachandran, Hollingshead et al. 2001). 
Several studies show that the toxin oligomerises in a circle and forms lytic pores 
after undergoing conformational change and thus penetrating the membrane of the cell 
(Korchev, Bashford et al. 1998; Marriott, Mitchell et al. 2008). Most of the structural 
biology studies use PLY concentrations of 10 µg/ml to 200 µg/ml, as either artificial 
liposomes, artificial membranes or erythrocytes were used (Korchev, Bashford et al. 1998; 
Kirkham, Kerr et al. 2006; Sonnen, Rowe et al. 2008). In pathological conditions, such as S. 
pneumoniae meningitis, the concentration on PLY in the cerebrospinal fluid (CSF) of 
patients never exceeds 0.2 µg/ml (Malmgren, Olsson et al. 1978) and thus is much lower 
(20-1000-fold) than used in those studies (El-Rachkidy, Davies et al. 2008). In this work 
the term “sub-lytic” shall be used, as only 10 % of the cells die in vitro and the toxin at this 
concentration causes changes in actin cytoskeleton (Fortsch, Hupp et al. 2011).  
 
1.3.2 Structural aspects of pneumolysin 
Pneumolysin is a protein-toxin with a size of 53 kDa and an amino acid length of 
471. It consists of four domains showing a slightly curved, but not globular shape 
(Marriott, Mitchell et al. 2008). In solution PLY itself stays monomeric and in rare cases 
forms dimers. 
 
1.3.3 Mechanism of pore-formation and membrane interaction 
The solved structure of PFO serves as a model for the monomeric form of PLY (Fig 
8). Both toxins have a secquence identity of 46% and a secquence similarity of 67% (Tilley, 
Orlova et al. 2005). Tilley et al. describe the pore-formation, exemplary on PFO, of PLY 
(Tilley, Orlova et al. 2005). The four domains of the toxin, mainly showing a β-sheet 
structure, also show a hydrophilic surface. Domains 1, 2 and 4 are arranged in a linear 
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manner, whereas domain 3 is attached loosely to domain 2 via a glycin-linker. Domain 4 
contains the cholesterol recognition site. This task is facilitated via a tryptophan-rich 
motif. Domain 3 is composed of a central β-sheet flanked by 2 groups of α-helices, which 
can refold into β-hairpins and thus insert into the membrane. If 50 oligomers form a pore, 
punching through the membrane with these β-hairpins, a hughe barrel-like structure 
would be formed creating a large pore of 350-450 Å (Solovyova, Nollmann et al. 2004). 
 
 
Fig 9: Mechanism of pore-formation (Tilley, Orlova et al. 2005). Domains 1, 2 and 4 of PLY are arranged in a 
linear manner, whereas domain 3 is attached loosely to domain 2 via a glycin linker. Domain 4 contains the 
cholesterol recognition site. This task is facilitated via a tryptophan-rich motif. Domain 3 is composed of a 
central β-sheet flanked by 2 groups of α-helices, which can refold into β-hairpins and thus inserts into the 
membrane. 
 
Next to its homology within the CDC-group, it has to be mentioned, that 
perfringolysin O shares structural characteristics with the membrane attack complex 
perforin (MACPF) of the complement system (Rosado, Kondos et al. 2008). The MACPF is 
used by the immune system as a defense against bacterial infection (Janeway, Travers et 
al. 1997). Thus, bacteria producing CDCs use the same structure for the attack of 
mammalian cells that is used by mammals for eliminating a bacterial infection. Here, the 
structural characteristics of the MACPF show a high structural similarity to the structure 
of the CDCs. Furthermore, a common size of the fold has been found (Rosado, Kondos et 
al. 2008). 
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1.3.4 Variants 
In order to accomplish experiments characterising the importance of pore-
formation in this work, negative controls are required. Two variants of PLY were used as 
non-pore forming variants of this CDC. These variants were developed in order to study 
the effect of PLY on the immune system (Berry, Alexander et al. 1995; Kirkham, Kerr et al. 
2006). The first variant shows an amino acid exchange at position 433. Here a tryptophan 
was replaced by a phenylalanin and this variant will be named PLY-W433F. The 
tryptophan in position 433 must have an essential functioning in the lytic capacity of the 
toxin. Thus, this variant only shows 1% of the lytic capacity, tested on erythrocytes, 
compared to the wildtype (Korchev, Bashford et al. 1998).  
The second variant used in this work will be named PLY-∆6. PLY-∆6 is incapable of 
forming pores as the mutation is located between domain 1 and 3, thus losing the 
capability to oligomerise (Garcia-Suarez Mdel, Cima-Cabal et al. 2004; Kirkham, Kerr et al. 
2006). Here two amino acids are deleted, A146 and R147 (Kirkham, Kerr et al. 2006). 
However, it remains unclear whether lytic pore formation and micropore formation 
(possessing ion channel-like properties), both of which are properties of the CDCs, are 
mechanistically similar or different phenomena. 
 
1.4 Cell trafficking 
In order to move, to achieve a metabolic exchange and to enable cellular signalling, 
the cell requires many components. The ones involved in movement, cellular 
reorganisation and transport are the previously mentioned cytoskeletal components, 
intermediate filaments, microtubules and the actin cytoskeleton. When it comes to 
transport into or through the cell more elements are required. Some of these 
mechanisms are not only important for transport and signalling, but also for the reaction 
to damages and subsequently for repair. 
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1.4.1 Endocytosis 
Endocytosis describes the process in which cells remove plasma membrane 
components and bring them to internal components into the cell. In this way an 
endosome is created. From these endosomes, internalised components can be degraded 
or recycled. Thus, new internal membranes are built from the plasma membrane lipid 
bilayer (Doherty and McMahon 2009). These transport mechanisms must be selective and 
tightly regulated. They can be classified into and biosynthetic-secretory and into an 
endocytotic pathway. Furthermore, classifications in mechanism are described by cellular 
components involved in these pathways. Reviewed by Doherty in 2006 ten possible 
mechanisms could be named: Clathrin mediated-, caveolin-dependent-, CLIC (Clathrin 
independent carrier)/GEEC (GPI-AP-enriched early endosomal compartment)-, 
IL2βpathway, Arf6 dependent-, flotilin-dependent endocytosis, as well as phagocytosis, 
macropinocytosis, circular dorsal ruffles and entosis (Doherty and McMahon 2009). For 
this work these mechanisms shall be summarised into four groups: caveolin- and clathrin-
dependent endocytosis as well as pinocytosis and phagocytosis. 
 
Fig 10: Summary of endocytotic mechanisms. Roughly, endocytotic processes can be divided in four groups: 
caveolin-dependent, clathrin-dependent, phagocytosis and pinocytosis. Several of these pathways depend 
on dynamin or different myosins. Albumin, transferrin and dextran are shown as potential markers for 
classical endocytotis pathways. Albumin is taken up via caveolin-dependent endocytosis (Bento-Abreu, 
Velasco et al. 2009), transferrin is taken up via clathrin-dependent pathways (Pearse and Robinson 1990) 
and dextran is internalised via phagocytosis (Costantini, Gilberti et al. 2011). 
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Summarised, it can be said, that endocytosis mediated by either clathrin or caveolin 
is receptor mediated (Clague 1998). Caveolin can be found in regions of the membrane 
that are rich in cholesterol, whereas clathrin forms crystal-like structures at the inner site 
of the plasmamembrane. Fluid-phase endocytosis/macropinocytosis describes the uptake 
of suspended or cell adherent particles, whereas phagocytosis is triggered by specific 
receptors (for mannose, complement, Fc, phosphatidylserine and scavenger) (Alberts 
2008). Both, pinocytosis and phagocytosis require an actin-cytoskeleton reorganisation in 
a RhoA GTPase dependent manner (Erridge 2010). Methodologically, these mechanisms 
can be recognised in live imaging by using fluorescence labelled structures that the cell 
takes up specifically. Albumin, for example, is taken up in a caveolae specific manner (see 
Fig 10) (Bento-Abreu, Velasco et al. 2009). Transferrin, an iron-binding protein, is 
internalised in a clathrin dependent manner (Pearse and Robinson 1990). Dextran is 
phagocytosed, meaning that the endosome fuses with an incoming phagosome during or 
shortly after internalisation (Costantini, Gilberti et al. 2011). By using these components 
experimentally, labelled with fluorescent dyes, one could follow their internalisation via 
live-imaging and differentiate between the several endocytic mechanisms. 
By using endocytotic actions the cell can escape for example from an attack by 
large- and small-pore forming toxins that trigger or enhance endocytic responses (Idone, 
Tam et al. 2008; Husmann, Beckmann et al. 2009; Tam, Idone et al. 2010; Thiery, Keefe et 
al. 2010; Los, Kao et al. 2011). In contrast, the pathogen could use this defence by the cell 
as a shuttle to cause further harm to the cell. For example, listeriolysin (another CDC) 
from Listeria monocytogenes enables listeria to escape from the phagolysosome after 
internalisation and to infect the cell from the cytoplasm. Endo- and also exocytosis can 
also serve as mechanisms to repair the cell membrane after injury (Bi, Alderton et al. 
1995; Idone, Tam et al. 2008). 
 
1.4.2 Exocytosis 
Excocytosis describes the process of vesicles fusing with the plasma membrane. 
Thus, it serves as a secretory pathway leading to the cell exterior. The cell can promptly 
secrete substances via exocytosis when it is triggered to do so. Furthermore, exocytosis 
can serve as a mechanism to enlarge the surface of the cell e.g. in fast growing cells or as 
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a repair mechanism after cell damage or injury. If a cell is wounded, a sudden increase in 
calcium triggers exocytosis by rushing into the cell (Alberts 2008). 
 
Fig 11: Exocytosis as a mechanism of membrane repair. Modified from Alberts (Alberts 2008). The cell can 
react with an increased exocytosis to wounding or to a decrease in overall membrane area e.g. by 
phagocytosis or cleavage.  
 
Several publications show that a calcium-regulated exocytosis is required for a 
resealing of the cell membrane after injury (Bi, Alderton et al. 1995), after challenge with 
the CDC Streptolysin O (Tam, Idone et al. 2010) or as a reaction of challenge with the α-
toxin from Staphylococcus aureus (Husmann, Beckmann et al. 2009). The argumentation 
is, that the exocytosis resealing process occurs within the first 30 seconds after toxin 
challenge, which indicates that the mechanism cannot be due to an automatic resealing 
by the bilayer. Here, the duration would be between 30 minutes to hours. This 
spontaneous resealing could be driven by the thermodynamic force that favours the 
bilayer (Bi, Alderton et al. 1995). 
 
1.4.3 Transcytosis 
Transcytosis serves the purpose to transport molecules across epithelial cells. A nice 
example described in a textbook (Alberts 2008) is that of a rat newborn. It takes up 
antibodies from the mother rat via milk and in the acidic pH of the gut these antibodies 
bind to certain receptors enabling a transport across the gut epithel. There, the process of 
endocytosis occurs enabling a further transport of the antibody. Transcytosis is not a 
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direct process but uses a route via endocytotic mechanisms to reach the target (Alberts 
2008). By crossing the BBB two mechanisms of transcytosis are used: vesicle mediated 
transcytosis and adsorptive mediated transcytosis. Vesicle mediated transcytosis 
describes the transfer of substances across the cell after the binding to a specific receptor 
leading to an internalisation via endocytosis. Adsorptive mediated transcytosis describes 
the transport of substances across the cell after a non-specific binding of a ligand to the 
cell surface charges and thus leading to an internalisation via endocytosis (Abbott, 
Ronnback et al. 2006).  
 
1.5 Neuroinflammation 
Inflammatory processes induced by an activated immune system play a role in CNS 
diseases. Here, microglia are activated within the CNS parenchyma (Lehnardt 2010). 
Innate immunity and neuroinflammation are mediated by Toll-like-receptors, which lead 
to an increase of proinflammatory cytokines (e.g. TNF-α) that cause neuronal injury in 
bacterial meningitis (Lehnardt, Massillon et al. 2003). The activation of innate immunity 
via Toll-like receptor 4 (TLR 4) might either trigger neurodegeneration (Lehnardt, 
Massillon et al. 2003) or increase neurogenesis, e.g. after experimental S. pneumonia 
meningitis (Gerber, Bottcher et al. 2003) or in postmortem brain sections of humans who 
died from meningitis (Gerber, Tauber et al. 2009). Nevertheless, activation of innate 
immunity via TLR 4 in meningitis remains controversial (Srivastava, Henneke et al. 2005; 
McNeela, Burke et al. 2010). Astrocytes have also been recognised as contributors to 
inflammatory responses by inducing a cytokine production and thus leading to an 
invasion of leukocytes into the brain. Furthermore, it has been shown that astrocytes 
express TLR 2,4, 5 and 9 (Shepard, Heuck et al. 1998). 
Some TLRs, such as TLR9, signal and thus activate inflammatory cytokines via 
endosomes (Krieg and Vollmer 2007). In contrast, other TLRs, such as TLR 2 and 4, are 
believed to signal via mechanisms on the plasmamembrane (McGettrick and O'Neill 
2010). Moreover, large- and small- pore forming toxins trigger or enhance endocytic 
responses (Idone, Tam et al. 2008; Husmann, Beckmann et al. 2009; Tam, Idone et al. 
2010; Thiery, Keefe et al. 2010; Los, Kao et al. 2011). Furthermore, an activation of TLRs 
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leads to a release of reactive oxygen species (ROS), such as NO and peroxide leading to 
oxidative stress (Steinborn, Seelos et al. 1999). 
 
Fig 12: Toll-like receptor signalling. From KEGG Pathways (http://www.genome.jp/kegg-
bin/show_pathway?org_name=mmu&mapno=04620&mapscale=1.0&show_description=show). TLR 2 can 
be activated by peptidoglycan (Gram+ bacteria) and TLR 4 can be activated by LPS (Gram- bacteria). 
Signalling can lead to apoptotic pathways or to the activation of stress-kinases (Mek/ ERK), which eventually 
leads to a production of proinflammatory cytokines such as TNF-α, IL-1β, IL-6 and IL-12 (p40). 
 
1.5.1 Innate immunity and Toll-like receptors 
The innate immune response serves as a precursor to adapted immunity (Janeway, 
Travers et al. 1997). The main task here is to lead phagocytosing cells and effector 
molecules to the site of infection (Baccala, Gonzalez-Quintial et al. 2009). The 
functionality of this immune response depends on specific receptors, which can be 
classified into three systems, which are summarised in the term of pattern recognition 
receptors (PRR). PRRs subdivide into Toll-like receptors (TLRs), retioid acid inducible gene 
like receptors (RLR) and cytosolic nucleic acid sensors and nucleotide-binding and 
oligomerisation domain (NOD) like receptors (NLRs). These three types can be found 
ubiquitously and show a high diversity. They recognise PAMPs (pathogen-associated 
molecular patterns) and DAMPs (damage-associated molecular patterns). In this work the 
focus will be laid onto TLRs (Baccala, Gonzalez-Quintial et al. 2009). 
TLR serve as a sensor in recognising infection with viruses and bacteria (Beutler 
2009). On the other hand the recent findings state that TLR are essential for an adaptive 
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immune response (Beutler 2009), whereas others line out evidence that adaptive 
immunity can be encountered without the signalling of TLRs (Blasius and Beutler 2010). 
TLRs can accomplish the signalling either intracellularly (TLR 3, 7, 8, 9, 13) or via actions 
on the membrane (TLR 2 and 4) (Beutler 2009; Blasius and Beutler 2010). Other TLRs are 
expressed on the cell surface, but the route and possible intracellular signalling cannot be 
explained for sure until today (Beutler 2009). TLRs can bind many factors, such as cell wall 
components of bacteria, RNA and DNA, but in terms of bacterial infection TLR2 and 4 shall 
be named here (Beutler 2009). TLR 2 serves the recognition of infection with Gram 
negative bacteria by recognising cell wall LPS of the pathogen. TLR 4 serves in the 
recognition with Gram positive bacteria by recognising peptidoglycan (Beutler 2009). 
Nevertheless, all possible studies in terms of a TLR signalling should be handled with care, 
as most protein purifications can be a source of LPS contamination and thus lead to false 
data concerning a signalling mechanism (Erridge 2010). 
 
1.5.2 Proinflammatory cytokines 
The activation of either TLR 2 or 4 will subsequently lead to a production of 
proinflammatory cytokines. These execute the function of leading phagocytic cells and 
effector molecules to the site of infection. Exemplary, the interleukines IL- 1, IL- 6, IL- 8, 
IL- 12 and TNF- α (Tumor necrosis factor α) shall be named. They fulfill local and systemic 
functions. IL-1 activates lymphocytes, leads to a local destruction of tissue and enables 
better access for effector cells. Subsequently, the production of IL-1 leads to a fever and 
production of IL-6. The production of TNF-α increases the permeability of vascular 
endothel and to results in an inflow of IgG and complement. This reaction leads to fever, 
shock and a mobilisation of metabolites. IL-12 activates natural killer cells and promotes 
differentiation of CD4-t-cells to tH1 cells. Futhermore, these pro-inflammatory cytokines 
activate the immune raction of the acute phase (Janeway, Travers et al. 1997; Borish and 
Steinke 2003). 
2 Aims 
 
22 
 
2 AIMS OF THIS WORK 
After challenge with Pneumolysin at sub-lytic concentrations small GTPases are 
activated and and microtubule-bundling is initiated. However, the possibility of a 
micropore formation with ion-channel like properties and a clustering of toxin molecules 
on the cell surface and thus leading to the observed effects could not be excluded. Thus, 
various Pneumolysin mutants should be investigated. First, one mutant, which is capable 
of membrane binding but incapable of pore-formation and membrane insertion called 
PLY-∆6. A second variant, PLY-W433F, would be able to penetrate the cell membrane, but 
bind to a lesser extent to the membrane. Here, the role of pore-formation on the changes 
in the model of primary mouse astrocytes should be investigated. The part of a possible 
pore-/micro-pore formation on the shape-changes in astrocytes, the ability to bind to the 
cell-membrane, and electrophysiological properties should be characterised. The 
objective was to determine the role of pore-formation on cytoskeletal remodelling (in 
terms of cell movement) and membrane depolarisation properties. For answering these 
questions, biochemical approaches, such as membrane fractionation and western blotting 
were to be used. In addition, the technique of the Planar Lipid Bilayer (PLB) should be 
used for an electrophysiological characterisation of possible pores in an artificial 
membrane. Membrane/cell movement was to be studied via various live-cell imaging 
approaches and immunocytochemistry. 
Furthermore, functional and pathophysiological aspects should be studied. The 
question of the toxin-fate after membrane interactions remains open. The impact of toxin 
and toxin-mutant treatments on cellular trafficking were of special interest. If the toxin 
would be internalised into the cell, where would it go and how would the fate of the cell 
be influenced. Again, live-cell imaging approaches with various dyes specific for endocytic 
events should be used. For a further clarification of cellular modifications, that could 
impact whole tissue, proinflammatory effects should be investigated via ELISA.  In order 
to link the actions of the toxin to disease relevant and brain-tissue modulatory effects this 
second project was tackled. 
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3 MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Chemicals 
All chemicals were supplied by Roth from Karlsruhe Germany. Chemicals used from other 
suppliers are listed in the table below. 
 
Table 1: List of used chemicals and providers. 
Chemical Manufacturer 
acetazolamid Sigma 
acetic acid Merck 
agarose MoBitec 
bafilomycin A Sigma 
boric acid Sigma 
cholesterol Sigma 
complete EDTA free Roche 
DAPI Invitrogen 
dimethylformamid (N,N) Merck 
diphytanoyl phosphatidylcholine Avanti Polar Lipids 
immobilon P, PVDF membrane Milipore 
PLO Sigma 
propidium iodide Invitrogen 
saccharose D(+) Applichem 
 
3.1.2 Buffers and solutions 
3.1.2.1 Buffers 
All buffers were prepared as aqueous solutions. 
Table 2: Used buffers. 
Buffers I Buffers II 
toxin labeling with Atto dyes: 
100 mM Tris-Cl 
1M, pH 9, Bicine 
crude membrane fractionation: 
200 mM sucrose 
Protease inhibitior added 1:100 before use 
planar lipid bilayer assay 
150 mM NaCl 
10 mM Hepes 
pH 7.4 
coating buffers (ELISA) 
a.) 0.2 M Sodium phosphate, pH 6.5 
b.) 0.1 M Sodium carbonate, pH 9.5 
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Buffers I Buffers II 
Laemmli 4x sample buffer 
0.25 M Tris-Cl (pH 6.8) 
8% SDS w/v 
30% Glycerol (v/v) 
Spatula tip bromphenol-blue 
imaging buffers for Ca-imaging  
with and without calcium (in brackets) 
135 mM NaCl 
(2 mM CaCl2) 
2 mM MgCl2 
4 mM KCl 
5 mM Hepes 
pH 7.4 
Trp-fluorescence 
50 mM Tris-Acetate 
100 mM K-Acetat 
pH 7.2 
NuPAGE SDS running buffer 20x 
(Invitrogen) 
50 mM MOPS 
50 mM Tris Base 
0.1% SDS 
1 mM EDTA 
pH 7.7 
Phosphate buffered saline (10x) 
1.3689 M NaCl, 26.8 mM KCl, 101.4 mM 
Na2HPO4, 17.6 mM KH2PO4 
lysis buffer 
0.1% Triton-X-100 in PBS 
 
 
3.1.2.2 Solutions 
Table 3: Used solutions. 
Solutions I Solutions II 
blocking solution for western blot: 
3% w/v milk powder 
1x PBS 
0.1% v/v tween in 1x PBS 
ECL plus western blotting detection 
reagents GE healthcare 1:40 (solution A:B) 
 
coomassie protein staining solution: 
10% v/v acetic acid 
50 % v/v methanol 
0.1 % w/ v coomassie R250 
in water 
coomassie destaining solution: 
10% v/v acetic acid 
50 % v/v methanol 
in water 
immunocytochemistry 
0.1 % v/v Triton-x 100 
4% PFA 
4% w/v BSA in PBS 
poly-L-ornithine (PLO) 
0.025% w/v in 0.15 M Boric acid 
cholesterol in ethanol 
100 mg/ 10 ml 
assay diluent (ELISA) 
10 % v/v FCS in PBS 
Bovine Serum Albumine (BSA) 
4% in 1x PBS (w/v) 
Artificial cerebrospinal fluid (ACSF) 
Volume = 1 L 
7.26 g NaCl, 0.186 g KCl, 0.242 g MgSO4, 
0.17 g KH2PO4, 2.18 g NaHCO3, 1.802 g 
Glucose, 1.37 g Saccharose, 0.368 g CaCl2 
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3.1.3 Antibodies 
3.1.3.1 Primary antibodies 
Table 4: List of used primary antibodies. 
Epitop Species Distributor Dilution 
Actin mouse Santa Cruz 1:1000 
Pneumolysin mouse Santa Cruz 1:200 
1:1000 (western blot) 
Vinculin mouse Genetex 1:400 
 
3.1.3.2 Secondary Antibodies 
Table 5: List of used secondary antibodies. 
Species directed 
against 
Species (origin) Company Conjugates 
mouse goat Jackson Immuno 
research 
cy3, cy5, FITC and 
1:200 peroxidase 
 
 
3.1.4 Reagents for cytochemistry and live imaging 
3.1.4.1 Dyes 
Table 6: List of dyes used for live imaging and immunocytochemistry. 
Dye  Distributor dilution/ concentration 
Albumin 555 Invitrogen, Molecular probes 0.1 mg/ ml 
Atto 488 NHS Ester Atto-tec GmbH In labelling 4:1 (Atto 
dye:toxin) 
BSA 488 Invitrogen, Molecular probes 1:10 
Dextran conjugates Roth 2 mg/ ml 
DiBAC4 Invitrogen, Molecular probes 500 nM 
FM 1-43 Invitrogen, Molecular probes 200 µg/ ml; 5 µg/ml 
Hoechst Invitrogen, Molecular probes 1:1000 
Phalloidine 488 Invitrogen, Molecular probes 5 µl/ ml PBS 
Propidium iodide Invitrogen Molecular Probes 1:1000 
Transferrin 555  Invitrogen Molecular probes 20 µg/ ml 
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3.1.4.2 Inhibitors 
Table 7: List of inhibitors used in live imaging experiments and immunocytochemistry. 
Inhibitor (Target) Distributor dilution/ final concentration 
Blebbistatin (myosin II) Calbiochem 2 µM 
Dynasore (dynamin) Calbiochem 60 µM 
Polymyxin B sulphate (LPS) Calbiochem 30 µM 
Protease Inhibitor (proteases) Roche 1:100 
 
3.1.5 Kits 
Table 8: Used kits and supplier. 
Purpose Kit Distributor 
Cytotoxicity Assay (LDH 
release) 
Cytotox 96® Non-
radioactive cytotoxicity 
assay 
LDH Cytotoxicity Detection 
Kit 
Promega 
 
Clontech 
Quantification of IL-1β, IL-6, 
IL-12 (p40), MCP-1, TNF-α 
ELISA BD 
 
3.1.6 Tools 
Surgical tools for tissue preparation:  Roth and Hartenstein 
Binocular:       Motic Microscopes, Roth 
Cell culture microscope:    Leica 
Vibratome: Vibroslice NVSL, World Precision Instruments, 
(Berlin, Germany) 
 
3.1.7 Protein Biochemistry 
3.1.7.1 SDS-PAGE and western blot 
Table 9: Materials for sodium dodecylsulphate polyacrylamide gel electrophoresis and western blotting. 
Material Distributor 
4-12% Bis Acrylamid gradient Gels 
Running Buffer 
Invitrogen 
4-12 % Bis Acrylamid Gels 
Running Buffer 
Anamed 
Polyvinylidene fluoride (PVDF) Membrane Milipore Immobilon P 
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Material Distributor 
x-ray film, Fujifilm Super RX Hartenstein 
fixer, Kodak Hartenstein 
developer, Kodak Hartenstein 
 
 
3.1.7.2 Columns and tubes 
Table 10: Other materials. 
Purpose Kit Distributor 
Size exclusion 
chromatography 
Econo Pac 10 DG desalting 
column 
Bio Rad 
Membrane fractionation Polycarbonate tubes Laborgeräte Beranek, 
Weinheim 
 
 
3.1.7.3 Protein purification (Glasgow) 
Escherichia coli XL-1 cells: Stratagene, Cambridge, UK 
HySoy J media: Sigma-Aldrich, Dorset, UK 
Dialysis buffer: 0.2 g/L KCl, 0.24 g/L KH2PO4, 1.44 g/L Na2HPO4, Sigma-Aldrich 
Amicon ultra-15 centrifugal filter tubes: Millipore, Watford, UK 
BioCAD 700E workstation: Applied Biosystems Ltd, Warrington, UK 
Limulus Amebocyte Lysate Kinetic-QCL Kit: Cambrex, Nottingham, UK  
 
3.1.8 Cell culture 
3.1.8.1 Media and antibiotics 
Leibovitz L 15, DMEM and BME-media were purchased from Invitrogen. 
Penicillin/ Streptomycin was purchased from Invitrogen. 
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3.1.8.2 Solutions and materials 
Table 11: Solutions and materials used in cell culture. 
Solution/ Material Distributor 
Trypsin EDTA 0.05% Invitrogen 
FCS (fetal calf serum) Pan Biotec 
cell culture flask Sardtedt 
dishes (60, 100 mm, 6-well, 12-well, 24-
well) 
Sardtedt 
hepes buffer solution 1M Invitrogen 
PLO (Poly-L-Ornithine) Sigma 
chambered slides BD 
cover glass chambered slides VWR 
 
3.1.9 Machines 
Microscopes:    Confocal System:   Leica TCS SP5 II 
Epifluorescent System:  Olympus Cell^M 
 
96-well-plate reader:   Biotek Instruments GmbH 
Chambers for SDS PAGE:  Invitrogen 
Table 12: Materials used for planar lipid bilayer. 
Tool Supplier 
Amplifier fabrication of Prof. Benz’s lab 
Electrodes Metrohm 
Electrometer Keithley 614 
Magnetic stirrer Hanna Instruments 
Oscilloscope OWON 
Recoder Rikadenki 
Teflon chamber fabrication of Prof. Benz’s lab 
Telescope Spindler und Hoyer 
Voltage Source fabrication of Prof. Benz’s lab 
 
Centrifuges: Beckmann ultracentrifuges, Optima™ 
TLX Ultracentrifuge 
Rotor TLA 120.2  
Luminescence Spectrometer : Perkin Elmer, LS50B 
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3.1.10 Software 
Program Supplier 
GraphPad GraphPad Software Inc., La Jolla, CA, USA 
imageJ version 1.43 for Windows, National Institute of Health, 
Bethesda, Maryland, USA 
Photoshop CS6 Adobe Systems Inc., USA 
spekwin32 Dr. Menges, Jena, Germany 
 
3.1.11 Animals 
SD rats were purchased from Charles River, mice (C57Bl/6) were purchased from Janvier. 
 
3.1.12 Other materials 
UV Cuvettes:  Roth 
Immersion-oil: Hartenstein 
Carbogen-gas:  Westfalia 
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3.2 Methods 
Parts of this section have already been published in (Fortsch, Hupp et al. 2011) and 
(Wippel, Fortsch et al. 2011). 
 
3.3 Biochemical assays 
3.3.1 Pneumolysin preparation 
PLY and variants of the toxin were kindly supplied by Professor Mitchell. PLY-W433F 
(partially non-lytic (1% of wild-type) mutant) was expressed in Escherichia coli XL-1 cells  
in HySoy J media and purified by hydrophobic interaction chromatography as described 
previously (Bakhiet, Olsson et al. 1993). Eluted fractions were run on SDS-PAGE and 
coomassie stained using standard protocols. Fractions containing >98% pure PLY were 
pooled and dialyzed overnight in phosphate buffer, prior to concentration using Amicon 
ultra-15 centrifugal filter tubes. The concentrated sample was then further purified by 
anion exchange with Poros HQ20 Micron chromatography media using the BioCAD 
700E workstation and introducing a 0 M to 1 M NaCl gradient. Lipopolysaccharide (LPS) 
content of purified toxin was determined using the Limulus Amebocyte Lysate Kinetic-
QCL Kit run according to manufacturer's instructions. All purified proteins had <0.6 
Endotoxin Units (EU)/µg protein. The purified toxin had an activity of ca. 5 x 104 
hemolytic units (HU)/mg. One HU was defined as the minimum amount of toxin, needed 
to lyse > 90% of 1.5 x 108/ml human erythrocytes within 1 h at 37°C.  
 
3.3.2 Protein content determination assay 
For protein content determination the BCA assay was used . A calibration curve with 
bovine serum albumin ranging from 2000 µg/ml down to approximately 15 µg/ml in serial 
dilutions was prepared. Analogue to dilution of the calibration curve the protein samples 
were diluted in PBS. The principle of the BCA test is the Biuret reaction based on the fact, 
that proteins build a complex with Cu2+-ions in an alkaline solution. Cu2+-ions are most 
probably reduced to Cu+-ions reacting to form a violet complex with bicinchoninic acid 
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and thus enabling a colorimetric determination of protein amount in a sample (Smith, 
Krohn et al. 1985). 
 
3.3.3 Enzyme-linked immunosorbent assay 
E nzyme-linked immunosorbent assay (ELISA) for IL-1β, IL-6, IL-12 (p40) and TNF-α 
were carried out as described by the manufacturer’s manual.  
 
 
Fig 13: Description of sandwich enzyme-linked immunodorbent assay. The target protein binds in the first 
step to the immobilized capture antibody (1). After a washing step the detection antibody was added (2). In 
the last incubation step the Horseradish-Peroxidase (HRP) was able to bind either to the biotin-coupled (3b) 
detection antibody or it was already bound to the detection antibody (3a). In the very last step, the 
substrate of HRP was added leading to a colorimetric reaction. 
 
A 96-well plate was covered with 50 µl of the capture antibody the night before at 
4°C in coating buffer. The plate was blocked for 1 h in assay-diluent. Subsequently, the 
plate was washed three times in washing buffer (PBS-T). A standard calibration curve was 
prepared ranging from 2000 pg/ml or from 1000 pg/ml in serial dilutions down to 0 
pg/ml. In total, eight calibration points were used, including maximum and minimum. 50 
µl of the sample and of the standard was added to each well. Each sample was 
determined in double measurements. After an incubation of 2 h, the plate was washed 
for five times. 50 µl of detection antibody was added per well. Either the detection 
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antibody was combined or already tagged with a streptavidin-HRP tag. Here, an 
incubation of 1 h followed. In other cases, the detection antibody was added for 1 h and 
following this step a streptavidin-HRP conjugate was added for an extra time of 30 min. In 
any case, after incubation the plate was washed thoroughly for seven times. 100 µl of 
tetra-methyl-benzidine (TMB) was added as a substrate for HRP leading to a colorimetric 
reaction. After 30 min the reaction was stopped with 0.12 M H2SO4. The colorimetric 
product turned from blue to yellow. Thus, the absorbance was measured at 450 nm with 
the plate reader. By producing a calibration curve, the amount of the different pro-
inflammatory cytokines could be calculated. 
 
3.3.4 Membrane binding properties of PLY-wildtype and variants 
Cells were treated with toxins at set concentrations (0.1-0.2 µg/ml) in 100 mm 
dishes. After treatment cells were washed with PBS. With the help of a cell scraper cells 
were harvested in 200 µl crude membrane fractionation buffer. Homogenisation was 
done, strictly at 4°C, via a syringe (Ø of 0.7 and 0.4 mm) by pipetting the cell lysate up and 
down for 20 times in the larger syringe and 10 times in the smaller syringe. Centrifugation 
at 900 x g for 10 minutes at 4°C removed cell debris. The pellet was discarded and the 
supernatant subjected to ultracentrifugation at 110.000 x g for 75 min at 4°C. The cytosol-
containing supernatant was transferred into a new tube, the pellet was inverted on 
cellulose paper and dried o.N. at 4°C and resuspended in lysis buffer the following day. 
Samples were stored at -20°C until SDS-PAGE and western blot were carried out. 
 
3.3.5 Cytotoxicity (LDH-release) assay 
The lactate dehydrogenase detection kit (Roche Diagnostics GmbH, Mannheim, 
Germany) was used in some experiments according to the manufacturer’s instructions to 
assess toxicity and cell lysis. After treatment of cells with toxin, lysis buffer (as a positive 
control) and medium as a negative control, medium was transferred into a new tube and 
cell debris was centrifuged down at 900 x g. The supernatant was assessed in the 
cytotoxicity assay. In triple measurements, 50 µl were added per well on a 96-well-plate. 
The substrate-mix was reconstituted in a dilution of 1:25. 50 µl of the substrate was 
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added to the samples and incubated for 30 min at RT. The reaction was stopped by 
adding 50 µl of 1 M HCl. The colorimetric reaction was measured via a plate-reader at a 
wavelength of 490 nm. 
 
Fig 14: Lactate dehydrogenase assay. From the clontech manual. 
 
3.3.6 Labeling of toxin with dye 
For the coupling reaction an NHS-Ester bond was selected, as no free amino-groups 
in the cholesterol binding loop were found (based on the pdb-file on Cα atoms of PLY). By 
labeling free amino-groups, an accidental inhibition of toxin-activity should be avoided. 
NHS-esters readily react with amino groups of proteins. The optimum pH range for NHS-
ester coupling is pH 8.0 – 9.0. At this pH amino-groups of proteins, i.e. the ε-amino groups 
of lysines are unprotonated to a high degree and highly reactive towards dye-NHS-ester. 
The dye was conjugated in 0.1 M Bicine buffer, pH 9, in and 4-fold molar excess to the 
toxin for 30 min at room temperature. The coupling reaction was stopped with 1/10 100 
mM Tris-Cl, pH 8 in order to add an excess of free amines. After the coupling reaction the 
protein was separated from the free dye by using size-exclusion chromatography. Here, 
the coupled protein will travel faster through the gel-filtration column compared to 
unlabeled dye. This is due to the selected pore-size of the matrix made of branched 
dextranes. As these dextranes show a high content of hydroxyl-groups, the polymer is 
hydrophilic and swells due to the mobile phase (Kleber, Schlee et al. 1990). Molecules 
that are larger than the resulting pores, e.g. the protein labeled with the dye, cannot 
enter the gel-matrix, whereas the dye itself can enter. For the elution it is possible to see 
3 Materials and Methods 
 
34 
 
to distinct bands passing during elution with PBS. The first fraction will be the labeled 
protein, the second band will be the uncoupled dye. Fractions were collected. Via SDS-
PAGE the labeled fractions were verified, by analyzing the Gel under a UV-Light 
transilluminator. Labelled fractions were pooled. Protein amount was verified by BCA 
protein assay and remaining cytotoxic activity was investigated by using LDH-assay. 
 
3.3.7 SDS-PAGE 
Under denaturating conditions, Sodium dodecyl sulfate is an anioinic detergent 
binding to hydrophobic areas of proteins and thus leading, next to a boiling of samples, to 
denaturation. The protein charges are covered by a strong negative charge, so that the 
proteins can be separated by size only in an electric field (Laemmli 1970). 
 
Fig 15: Description of protein migration in electric field during SDS-PAGE. The negatively charged proteins 
migrate in the electric field to the cathode. 
 
Gradient gels of 4-12% polyacrylamid were purchased from Invitrogen. The protein 
samples were boiled for 3 min at 95°C in order to denaturate the proteins. Subsequently, 
samples were stored on ice to avoid renaturation. Laemmli buffer was added for the 
purpose of covering the own charges of proteins with negative charges. When the 
samples were applied to the gel, an electric field was applied in order to separate the 
proteins migrate to the cathode. Electrophoresis was carried out at 200 V for 2 h.  
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3.3.8 Western blot 
Western blotting serves the purpose to transfer proteins after finished SDS-PAGE 
onto a PVDF Membrane. This enables the experimenter to detect proteins specifically 
with the help of antibodies, as a PVDF membrane exhibits higher stability compared to a 
fragile gel. Here, the method of semi-dry blotting was used. 
Again the proteins were transferred to the cathode. After protein-transfer, 
membranes were blocked in 3-5% milk-powder in PBS-T. Subsequently, membranes were 
incubated with primary antibody for 1 h at room-temperature in blocking solution and, 
after tree times washing in PBS-tween, incubated with secondary antibody for 1 h at 
room-temperature in blocking solution. The secondary antibody was linked to HRP which 
uses luminol as a substrate and leads to a chemiluminescence reaction. This 
chemoluminescence is captured on a x-ray film in a dark-room and after exposure 
subsequently developed and fixed. 
 
 
Fig 16: Semi-dry western blotting. Proteins separated on the polyacrylamide gel are transferred onto the 
PVDF membrane in the direction of the cathode. Gel and membrane are enclosed by blotting paper and all 
are soaked in transfer buffer. Again, the negatively charged proteins migrate in the electric field from the 
gel onto the PVDF membrane. 
 
3.3.9 Preparation of cells 
Primary mouse astrocytes (PMA) were prepared from cortices of postnatal day 4-6 
newborn C57/Bl6 mice. Mice were decaptivated and brains were put into dishes 
containing ice-cold 1x PBS. Meninges and the cerebellum were removed with surgical 
tools under a binocular. The remaining tissue was sheared into smaller pieces by using a 
pasteur pipette. The cells of 2 brains were seeded in 75 cm2 poly-L-ornithine-coated cell 
culture flasks in DMEM. 
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3.3.10 Seeding of cells 
Prior to treatment, the cells had to be reseeded into the reaction vessel. For live 
imaging coverslip chamber slides were used. In immunocytochemical assays chambered 
slides were used. For biochemical assays, either 100 mm dishes or 6-, 12-, or 24-well 
plates were used. 4-16 h prior to seeding, reaction vessels were covered with poly-L-
ornithine at 37°C and 5% CO2 in order to provide a matrix for the primary mouse 
astrocytes. Before seeding the astrocytes were rinsed wit 2 ml of Trypsin. Subsequently, 
the cells were incubated with 2 ml Trypsin until trypsination at 37°C and 5 % CO2 was 
completed. Trypsination was stopped by adding 8 ml of full medium to the flask. After 
rinsing the cells via a pipette, the complete volume of 10 ml was collected in a 10 ml tube 
and cells were centrifuged at 240 x g. The cells were then seeded into the reaction dishes. 
Per 6-, 12- or 24-well plate one 75 cm2 cell-culture flask of cells was used. In the case of 
chambered slides (containing 4 reservoirs) 1/8 of a flask was seeded. 
 
3.3.11 Culture treatment 
Cells were treated with pneumolysin and variants at final concentrations of 0.1-0.2 
µg/ml. Inhibitors were used at the following final concentrations: 2 µM blebbistatin 
(inhibitor for myosin II), 60 µM dynasore (inhibitor for dynamin). Dyes were used 
according to Table 6. 
 
3.3.12 Preparation of acute brain slices 
Acute brain slices were prepared from postnatal day (PD) 4-6 newborn SD rats and 
C57Bl/6 mice by decapitation and vibratome sectioning (300 µm slices) in artificial 
cerebrospinal fluid (Wippel, Fortsch et al. 2011). Slices were continuously oxygenised with 
carbogen gas (95% O2, 5% CO2) at 4°C. The slices were allowed to adapt in carbogenated 
BME medium with 1% penicillin/streptavidin and 1% glucose at 37°C for 1 h before being 
challenged with PLY in the 5% CO2-buffered medium (pH=7.3). Medium and toxin were 
mixed with 30 mM polymyxin B and pre-incubated at 37°C for 30 min. Toxin dilution and 
control solution, with and without polymyxin B, were added to brain slices for 5 h. Slices 
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were carbogenated during incubation. Samples were taken and either measured 
immediately via ELISA or stored at -80°C. 
 
3.4 Live imaging experiments 
For live imaging experiments, the cells were pre-incubated in pH-insensitive L-15 
Leibovitz medium at 37°C without phenol-red and without FCS. This medium was selected 
as described previously (Goldman, Swedlow et al. 2010). After testing of primary mouse 
astrocytes in a 24 h imaging and confirmation of cell viability, this medium was selected. 
Compared to cultivation medium (DMEM) without phenol-red being buffered with hepes 
leibovitz’s medium does not show toxicity compared to 15 mM Hepes buffered medium. 
The medium had to be free of any indicator as phenol red can interfere with the spectral 
properties of the dyes used for live imaging. Upon treatment the cells were visualised on 
an Olympus Cell^M imaging system using 10x and 20x dry objectives. The rate of 
endocytosis was visualised by cell incubation with the FM1-43 lipophilic styryl dye at a 
final concentration of 50 µg/ml using an Olympus Cell^M system. Additionally, the 
dependency of the dye on endosome acidification was tested by pre-treating cells with 
10 nM Bafilomycin A in order to prevent endosomal acidification. Membrane 
depolarisation was visualized using DiBAC4 at a final dilution of 1:10 000. This was 
optionally achieved by imaging on the confocal system. Here, one well after the other was 
imaged. In all experiments, cells and tissues were treated with PLY and inhibitors in 
serum-free medium. In live imaging experiments, the cells were starved for 60 min to 
24 h before exposure to the toxin in order to deprive the medium of cholesterol. Cells 
were analysed by simultaneous observation of toxin-treated and mock-treated cells with 
automatic repositioning of the microscopic stage with a precision of 1 µm (according to 
manufacturer’s instructions) per single move. All images were processed with ImageJ.  
 
3.5 Immunofluorescent staining 
PMA were cultivated in chamber slides and starved 60 min in advance to treatment. 
After co-treatment with 0.1-0.2 µg/ml of PLY-WT GFP and either albumin, dextran or 
transferrin for 4 min, cells were fixed in 4% PFA. Samples were preserved by covering in 
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mowiol and visualised with a Leica SP5 microscope, using a 63x oil immersion objective. 
Image processing and analysis was performed with ImageJ.  
For visualisation of focal adhesions, cells were fixed in 4% PFA after treatment, 
permeabilized in 0.1% TritonX-100 and blocked in 4% BSA. Between these steps, slides 
were washed in PBS. After the blocking step, fixated cells were incubated for 1 h with FITC 
coupled Phalloidin and with the mouse anti-vinculin antibody. After incubation with the 
primary antibody and another washing step, the incubation with the goat anti-mouse cy3 
coupled antibody followed. After three washing steps, the slide was preserved by 
covering with mowiol. 
 
3.6 Planar lipid bilayer (PLB) 
The planar lipid bilayer experiments were carried out as described previously (Benz, 
Stark et al. 1973; Benz, Janko et al. 1978). The properties of membranes, namely to 
prevent electric currents to pass the membrane, are used in this assay. If a pore is formed 
in the artificial membrane e.g. by a pore-forming toxin, the conductance across the 
membrane will increase. The formation of a pore can be observed as a conductance step 
in the electrophysiological recording. For this method, a teflon chamber consisting of two 
reservoirs is required. The wall between the two chambers shows a hole with an area of 
ca. 0.5 mm2. This chamber is inserted in a metal box serving as a faraday cage and thus 
preventing an influx of external forces. Membranes were formed from a 1% (w/v) 
solution of diphytanoyl phosphatidylcholine (PC) in n-decane. 25% cholesterol (w/w) was 
added to simulate cholesterol content in an astrocyte membrane. The lipid was spread 
with a Teflon loop over the small hole in the wall between two chambers containing the 
aqueous buffer. 
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Fig 17: Formation of planar lipid bilayer. The top-panel shows the Teflon chamber with two reservoirs. The 
blue line represents the bilayer, which is magnified at the bottom-panel. At first Newton rings are visible (a). 
When the membrane turns black the lipid bilayer with a thickness of about 5 nm has formed (c). 
 
The thin lamella shows at first the newton colours. After a time the membrane will 
turn black, indicating a formation of a lipid bilayer with a thickness of about 5 nm 
resembling the thickness of a biological membrane. 
The toxin (0.1 µg/ml - 0.3 µg/ml) was added to the cis-side in the aqueous phase 
after the membrane had turned black. The membrane current was measured with a pair 
of Ag/AgCl electrodes with salt bridges switched in series with a voltage source and a 
highly sensitive current amplifier. The electrode at the cis-side was connected to the 
voltage source, whereas the electrode at the trans-side is connected to the amplifier. The 
temperature was maintained at 20°C throughout. 
In order to answer the question, whether a pore from the toxin shows a certain 
selectivity for cations or anions, the ion-selectivity had to be determinded. Ion-selectivity 
depends on the charge distribution at the entrance to the pore. While testing for an ion-
selectivity, a concentration gradient is established between the two reservoirs. If the pore 
shows a specificity for a certain sort of ion, it will be transported, or it will diffuse to the 
reservoir following the concentration gradient. Here a difference in potential can serve as 
an indicator for an ion-selectivity. 
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3.7 Evaluation and statistics 
Image processing and image analysis were performed using ImageJ software. 
Statistical analysis was performed on GraphPad Prism 4.02 for windows. Statistical tests 
included Mann-Whitney U-test (comparing two groups differing with one parameter at a 
time) or one-way ANOVA with Bonferroni post test (comparing three or more groups, 
differing with one parameter at a time). 
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4 RESULTS  
Parts of this section have already been published in (Fortsch, Hupp et al. 2011) and 
(Wippel, Fortsch et al. 2011). 
 
4.1 Characterisation of wildtype and variants 
4.1.1 Lytic capacities 
The lytic capacities of PLY-WT, PLY-W433F and PLY-∆6 were estimated by measuring 
the release of Lactate-Dehydrogenase (LDH) from primary mouse astrocytes (PMA) into 
the medium. The positive control, thus releasing 100% of LDH, was treated with the lysis 
buffer. All colorimetric measured quantities are shown as a percentage in relation to the 
positive control. Resulting, PLY-WT showed a lytic capacity in 4 trials of almost 100%, 
compared to PLY-W433F and PLY-∆6, confirming previous data that these variants are 
incapable of forming a pore and thus cause cell lysis. 
 
 
Fig 18: Comparison of LDH-release after toxin-challenge. Only PLY-WT causes a release of LDH, whereas the 
non pore-forming variants cause a release similar to that of untreated cells. Values represent mean +/- 
SEM. 
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Furthermore, a classification of lytic capacities was achieved via live-imaging. Thus, 
a definition for lytic and non-lytic abilities should be found. Here, cells were challenged 
with 0.1-0.5 µg/ml PLY-WT and co-stained with propidium-iodide. This chromatin stain 
with a molecular weight of 668 g/mol should easily enter through macropores and stain 
chromatin in the nucleus of lysed cells, but it cannot pass an intact biological membrane. 
The rate of permeabilisation was evaluated by judging the effectivity of PI-Staining. 
Permeabilisation of the cells occurred in an exponential manner, reaching a plateau at all 
concentrations not later than 40 min after PLY-WT challenge. As the concentration of PLY-
WT rose, the half-time of cell permeabilisation dropped from ca. 22 min (0.05 µg/ml) to 
ca. 6 min (0.5 µg/ml). As soon as the plateau was reached, two defined populations of 
cells – permeabilized (PI-positive; accounting for about 10% of cells at 0.1 µg/ml PLY) and 
non-permeabilised (ca. 90% of the cells at 0.1 µg/ml PLY) were formed and remained 
unchanged with the time. 
 
 
Fig 19: Evaluation of lytic capacity of PLY-WT by propidium iodide. In any case a plateau was reached. At the 
highest concentration of PLY-WT the plateau was reached in the shortest time. Values represent mean +/- 
SEM (Fortsch, Hupp et al. 2011). 
 
4.1.2 Membrane binding properties of pneumolysin wildtype and variants 
In order to see, whether the variants bind to the membrane in the same manner as 
the wildtype, an assay visualising the membrane binding was established. Here, 100 mm 
dishes were treated with the same concentrations of PLY-WT, PLY-W433F and PLY-∆6. 
After cell harvest, cells were subjected to ultracentrifugation at 110.000 x g for 75 min at 
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4°C. This served the separation of cytosol from membrane. All fractions were separated 
via SDS-PAGE and transferred on a PVDF membrane via western blotting. The reactivity of 
a specific pneumolysin antibody served as mean value to visualise the binding. An 
antibody directed against actin served as a loading control. Even if the variants PLY-
W433F and PLY-∆6 are incabable of showing any lytic capacity, both can bind to the 
membrane. Nevertheless, it is worth mentioning, that PLY-W433F binds to a lesser 
extend, which can be explained by the site of mutation. The tryptophan in position 433 is 
located in the tryptophan-rich loop, which is supposed to be important for cholesterol 
recognition. Tryptophan 433 seems to be essential for this recognition and one could 
assume, that a mutation to a phenylalanin leads to a lesser depth of binding in the lipid 
bilayer due to the hydroxyl group and thus a slightly increased hydrophility. 
 
Fig 20: Membrane-binding capacities of PLY-WT, PLY-∆6 and PLY-W433F at 0.1-0.3 µg/ml. The wildtype and 
the variants all bind to the membrane. Only PLY-W433F seems to bind to a lesser extent. 
 
4.1.3 Membrane depolarisation 
DiBAC4, a voltage sensitive dye, serves as a marker for membrane depolarisation. A 
change in membrane potential is accompanied by changes in the optical properties of the 
dye. If the membrane is depolarised, the dye can enter the cell and interact with cytosolic 
proteins. This interaction leads to an increase in fluorescence. Large changes in 
fluorescence do not cause a mitochondrial uncoupling (Epps, Wolfe et al. 1994). Thus, if 
4 Results 
 
44 
 
the membrane potential changes, one could observe, if it is due to a membrane binding 
or a possible pore-formation.  
 
Fig 21: Schematic demonstration of the membrane potential. Left: intact membrane potential, DiBAC4 
would not be able to pass through the membrane. Right: depolarised membrane, DiBAC4 can reach the 
cytosol and interact with cytosolic proteins, thus increasing fluorescence.  
 
In fig 22 it is clearly visible, that only PLY-WT causes a depolarisation of the 
membrane indicated by the increase in fluorescence of DiBAC4. The variants showed no 
change. All graphs were normalised to the untreated control. This data shows the 
independence of membrane depolarisation to membrane binding. Even if the PLY-
variants bind to the cell membrane, the depolarisation cannot be caused by membrane 
binding. The option left to discuss would be a micro-pore formation of PLY-WT in contrast 
to the non pore-forming variants. 
 
Fig 22: Membrane depolarisation induced by PLY-WT compared to PLY-∆6 and PLY-W433F. Only PLY-WT 
caused a visible increase in membrane depolarisation. Values represent mean +/- SEM. 
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4.1.4 Tryptophan fluorescence 
The methodology of measuring tryptophan fluorescence is known to show a change 
of absorbance spectra, if the polarity of protein environment changes (Vivian and Callis 
2001). Thus, if Pneumolysin binds to membrane cholesterol in the membrane, a shift in 
Tryptophan fluorescence should be observed, as the protein dips from an aqueous phase 
into the membrane lipid bilayer. Furthermore, the variant PLY-W433F, lacking one 
tryptophan, should exhibit a different tryptophan fluorescence and spectral behavior. Fig 
23 shows the different tryptophan spectra. PLY-WT, PLY-W433F and PLY-∆6 were pre-
incubated with cholesterol. Compared to the cholesterol-free spectrum, a shift of the 
maximum of 7-10 nm was observed showing that the pre-treatment with cholesterol 
abolishes the membrane binding capacity to membrane cholesterol. PLY-WT and the 
variants show the same shift. Due to the pre-treatment with cholesterol, the cholesterol 
binding site was saturated and the toxins could not bind to membrane cholesterol. 
 
 
Fig 23: Shifts in tryptophan Fluorescence after challenge with PLY-WT, PLY-∆6 and PLY-W433F. Dotted line 
shows treatment with PLY-WT pre-incubated with cholesterol, full line shows pre-treatment without 
cholesterol. 
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4.1.5 Planar lipid bilayer 
The characterisation of the PLY-variants should also be carried out in an artificial 
system, in order to avoid cellular effects caused for example by endocytosis. Here, the 
pore-froming capability should be characterised in an artificial lipid bilayer system in 
aqueous buffer. Fig 24 shows that PLY-WT causes smaller oscillations (up to 25 pA at 170 
mV) indicating an activity of the toxin at the artificial bilayer. PLY-W433F shows small and 
infrequent oscillations compared to PLY-WT. PLY-∆6 showed no oscillations at all. All 
treatments were carried out at comparable concentrations. These data indicate that only 
the PLY-WT is capable of forming a pore. 
The measurement of ion-selectivity is described in 3.6. Here, only PLY-WT has been 
measured, as the wildtype is the only variant capable of forming a pore. However, only a 
slight selectivity for cations could be determined as seen in Table 13. 
 
 
Table 13: Determination of ion-selectivity for PLY-WT pores in PLB. A slight cation selectivity is visible. 
Electrolyte Values MEAN 
KCl 1.16 
1.19 
1.27 
1.23 
1.23  slightly cation 
selective 
 
 
 
4 Results 
 
47 
 
 
Fig 24: Electrophysiology in planar lipid bilayer of PLY-WT, PLY-∆6 and PLY-W433F. The arrow indicates one 
step-wise increase of ion-conductance. Each step represents one pore in the bilayer. 
 
In order to further clarify, if pores formed depend on calcium, the conductance of 
PLY-WT pores under different calcium-conditions was investigated. It becomes clear that 
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the distribution of pores shows a comparable pattern under different calcium conditions 
(0 mM, 1 mM and 2 mM calcium). 
 
 
Fig 25: Distribution of PLY-WT pore-sizes in planar lipid bilayer under different calcium conditions. No 
dependency of pore-size/conductance changes across the artificial membrane on calcium could be 
observed. In addition, no different pore-sizes in different calcium concentrations could be observed. 0 mM 
calcium = 225 pores, 1 mM calcium = 325 pores, 2 mM calcium = 267 pores. 
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4.1.6 Cell displacement 
In order to complete the comparison of PLY-WT, PLY-W433F and PLY-∆6, the effect 
of these variants on the movement of the cells was followed in time-lapse live-imaging 
experiments. Both variants PLY-W433F and PLY-∆6 did not show any ability to cause 
displacement after toxin challenge, whereas PLY-WT showed a significantly greater cell 
displacement. The cells were treated with PLY-WT or variants. The films were analysed 
with imageJ. For this the cell border of the initial time-point up to the last time point was 
tracked. These tracks are on top of the microscopy panel in Fig 26. 
 
Fig 26: Cell retraction after PLY-WT treatment. It becomes clearly visible that only PLY-WT causes cell 
retraction, whereas in treatment with PLY-variants the cells stay calm comparable to untreated control 
cells. Values represent mean ± SEM, n = 40–60 cells of four experiments. The red line in the graph indicates 
automatic stage repositioning shift. Scale bars: 10 μm. Published in Fortsch and Hupp et al. (Fortsch, Hupp 
et al. 2011). 
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4.1.7 Cell adhesion 
Effects of the PLY-WT and the variants on the movement of astrocytes should be 
described. Focal adhesions stand for cellular movement. If the cell retracts from or moves 
towards cellular stressors, on the end of the cell, adhesion points are loosened, whereas 
in front of the cell new adhesions are fromed pulling the cell forward. Considering 
previous data and experiments, a difference in cell movement or displacement should be 
observed comparing PLY-WT with the variants. Here, PLY-WT compared to the variants 
showed in most cases more and larger focal anhesions, confirming the data on cell 
dicplacement.  
 
 
Fig 27: Staining of primary rat astrocytes with phalloidin-alexa 488 and vinculin-cy3 antibody for 
visualisation of focal adhesions. In PLY-WT treated cells long and strong focal adhesions are visible, whereas 
in the PLY-variant and control treated cells the focal adhesions have a far smaller appearance. Scale bar = 10 
µm. 
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4.2 Effects on endocytosis 
4.2.1 FM 1-43 dye 
For a general observation of endocytotic events, FM-Lipophilic styryl dyes were 
used. These dyes insert into the outer leaflet of membranes and cannot flip-flop across 
the membrane due to a charged and thus polar head group. If endocytosis occurs, the dye 
is internalised in the endosome and after acidification of the endosome, the fluorescence 
of the dye increases. In order to evaluate, whether the increase in fluorescence depends 
on the acidification of the endosome, cells were imaged with FM 1-43 and a 
preincubation with bafilomycin A. This antibiotic prevents the acidification of the 
endosomes (Bowman, Siebers et al. 1988). It is visible, that the fluorescence intensity of 
FM 1-43 depends on the acidification of the endosome as no fluorescence increase of FM 
1-43 after toxin treatment can be observed, when cells have been pre-treated with 
Bafilomycin A. All values have been normalised to the corresponding control. 
 
 
Fig 28: Inhibition of fluorescence caused by FM 1-43 after inhibition of endosomes acidification. 
Fluorescence intensity of FM 1-43 depends on endosomal acidification. Values represent mean +/- SEM. 
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4.2.2 Variants 
Following the characterisation of the variants under different conditions, cellular 
effects should be described. Fig 29 shows the rate of endocytosis after toxin challenge. 
The FM 1-43 dye was applied to the cells 30 min prior to treatment in order to allow an 
equilibration of the dye in the course of normal rate endocytosis. At 3-5 min after 
treatment of the primary mouse astrocytes with 0.2 µg/ml of PLY-WT, PLY-W433F and 
PLY-∆6 only the PLY-WT causes an increase in endocytotic rate. This reaches a plateau 
after 7-8 min. The graph shows the data of the variants normalised to untreated control 
cells. 
 
 
Fig 29: Real-time monitoring of endocytotic processes with FM1-43 dye. Comparison of PLY-WT, PLY-∆6 and 
PLY-W433F. Only PLY-WT causes an increase in overall endocytosis. Values represent mean +/- SEM. 
 
4.2.3 Effects of inhibitors on endocytosis 
As effects on endocytotic behaviour of the cells were observed, a mechanistic 
explanation should be attempted. Here two inhibitors were used. The first inhibitior 
dynasore, inhibits the GTPase activity of dynamin. The second inhibitor blebbistatin 
inhibits seletively and potently nonmuscle myosin II. The inhibitors and the FM 1-43 dye 
were applied 30 min prior to toxin challenge at concentrations of blebbistatin at 2 µM 
and dynasore at 60 µM. The cells were challenged with 0.2 µg/ml of PLY-WT. Fig 30 
depicts the effect of the two inhibitors on the endocytotic rate in co-treatment with PLY-
WT. The wildtype alone causes an increase in overall endocytic rate, whereas treatment 
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with dynasore and both inhibitors lead to no change in the endocytotic rate. Co-
treatment of cells with Blebbistatin and PLY-WT shows a much stronger increase in 
endocytic rate compared to the wildtype.  
 
 
Fig 30: Real-time monitoring of endocytotic processes. Inhibition of dynamin, myosin II, both and no 
inhibitor are shown. Inhibition of myosin II leads to a stronger increase in overall endocytosis compared to 
PLY-WT treatment without inhibitor. Inhibition of dynamin and dynamin/myosin II leads to a decrease in 
overall endocytic rate compared to treatment with PLY-WT alone. Values represent mean ±SEM. 
 
4.2.4 Effects of inhibitors on membrane depolarisation 
As inhibitors of dynamin and myosin II showed effects on endocytosis the question 
remained what the effect on membrane depolarisation would be. If the endocytotic 
processes serve as a possible rescue mechanism of the cell, after pore or micro-pore 
formation, the depolarisation pattern could change. Again, cells were pre-treated with 
dynasore, blebbistatin, or both and after 30 min challenged with 0.2 µg/ml PLY-WT. In Fig 
31 it is visible that the wildtype alone causes a depolarisation of the cell. This 
depolarisation is comparable to the treatment with both inhibitors. Cells pre-treated with 
dynasore alone show more depolarisation compared to the wildtype, whereas pre-
treatment with blebbistatin alone leads to a smaller increase of depolarisation compared 
to the treatment without inhibitors. All values are normalised to untreated control cells. 
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Fig 31: Real-time monitoring of membrane depolarisation. Dynasore and blebbistatin or both inhibitors 
were applied prior to toxin treatment. Membrane depolarisation is increased after inhibition of dynamin 
compared to cells treated with PLY-WT alone. Inhibition of myosin II led to a decrease of membrane 
depolarisation. Inhibiting dynamin and myosin II, the level of depolarisation is comparable to cells treated 
without inhibitor with PLY-WT alone. Values represent mean +/-SEM. 
 
4.2.5 Calcium dependency 
Before and during toxin challenge, cells were kept in medium either containing 2 
mM calcium or in medium containing no calcium. Calcium, being possibly involved in 
membrane repair mechanisms, turned out not to make any difference in the pore-size 
distribution in the planar lipid bilayer Fig 25. Different calcium conditions were applied 
and release of LDH was measured in order to evaluate the impact of different calcium 
conditions on cytotoxic effects of PLY-WT. As shown in Fig 32 the depletion of calcium 
from the medium causes a much higher lytic capacity of PLY-WT. In further treatments 
without calcium, the toxin concentration was adapted to a concentration that would turn 
out to be non-lytic. 
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Fig 32: Measurement of cytotoxicity by measuring the release of Lactate-Dehydrogenase in different 
calcium conditions. +Ca = 2 mM, -Ca = 0 M Ca. Values represent mean +/-SEM. Figure also published in 
(Wippel, Fortsch et al. 2011). 
 
By using different calcium concentrations in medium, at 2 mM or 0 mM calcium, the 
possible effect of calcium on the endocytotic rate of PLY-WT should be determined. As 
the toxin concentration in calcium-free conditions was adapted to a sub-lytic 
concentration, one can say that the observed effects are not due to a higher toxicity of 
PLY-WT. Under calcium-free conditions, the endocytic rate was three times higher than 
under calcium-containing conditions.  
PLY-WT is thus not only more lytic in calcium-free conditions, but Ca2+ seems to play 
an inhibitory role of the rate of endocytosis induced by PLY-WT. 
 
Fig 33: Real-time imaging of endocytotic processes by using FM 1-43 dye in the context to calcium 
dependency. +Ca2+ = 2 mM, -Ca2+ = 0 M. Endocytic rate is increased about 3-fold compared to treatment 
with PLY-WT with calcium. Values represent mean +/- SEM. 
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4.2.6 Endocytotic markers 
4.2.6.1 Internalisation of PLY-WT 
PLY tagged with GFP was visualised on a confocal system. In addition, several 
inhibitors on endocytotic adaptor proteins, dynamin and myosin II, were used as co-
treatment. In Fig 34 it becomes visible that PLY-GFP is internalised to a higher extent, 
when the primary mouse astrocytes were pre-treated with dynasore or both inhibitors. If 
the cells are just treated with PLY-GFP or pre-treated with blebbistatin the level of 
internalisation is comparable. 
 
Fig 34: Internalisation of PLY-WT by using A) no inhibitor, B) dynasore C) blebbistatin and D) both inhibitors. 
The scale bar represents 10 µm. An orthogonal view was produces via imageJ. Vertical white line represents 
the XZ plane, whereas the horizontal white line represents the XZ plane. These planes are represented at 
the side (YZ) and at the bottom (XZ) of the stacks. Nuclei are stained with propidium iodide  in blue. PLY-GFP 
is represented in gray values. Orthogonal views were produced in cells that are negative for PI staining and 
thus are not lysed. 
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4.2.6.2 Albumin, dextran and transferrin 
Albumin is taken up via caveolin dependent mechanisms (Bento-Abreu, Velasco et 
al. 2009). Thus labelled albumin would serve as a marker for caveolin dependent 
endocytosis and in a co-staining with GFP-tagged PLY (PLY-GFP) a possible explanation for 
the internalisation of the toxin could be found. Dextran is taken up into the cell via 
phagocytosis (Costantini, Gilberti et al. 2011), as it consists of branched sugar molecules 
and has a high molecular weight. In a co-staining with PLY-GFP the mechanism of 
phagocytosis could be analysed and the question could be answered if it applied for the 
uptake of the toxin. Transferrin is a soluble protein that carries iron in the blood. If 
transferrin is endocytosed, it carries the bound iron to the endosomes (Pearse and 
Robinson 1990). If the endosome is acidified, transferrin releases the iron. Transferrin is 
endocytosed in a clathrin dependent manner. A staining with transferrin would highlight 
clathrin mediated endocytotic processes. Here, PLY tagged with green fluorescent protein 
(PLY-GFP) and transferrin labelled with Rhodamine were visualised to find a possible co-
localisation. 
In fig 35 it is visible that PLY-WT and all the above mentioned markers for 
endocytotic processes are internalised. However, PLY-GFP shows no co-localisation with 
either albumin, dextran or transferring, excluding these pathways as possible 
internalisation mechanisms for PLY-WT. 
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Fig 35: Internalisation of albumin, dextran and transferrin. Co-staining with PLY-WT tagged with GFP 
showed no co-localisation. The scale-bar represents 10 µm. Magnified pictures are shown in the right panel 
and are indicated via red lines. 
 
4.3 Immunological aspects 
The previously presented data showed that the cells respond in different manners 
to the PLY-variants and the wiltype. While PLY-WT causes an increase in overall 
endocytosis, the variants show no differences. The pathological meaning of the described 
effects shall be characterised by looking more closely at proinflammatory cytokines. IL-1β, 
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IL-6, IL-12 (p40) and TNF-α were investigated. Of all these proinflammatory cytokines only 
IL-6 showed an increase in primary mouse astrocytes.  
 
Fig 36: Comparison of all tested interleukins. No difference in IL-1β, TNF-α and IL-12 (p40) were found in 
measurements with and without Polymyxin B. Only IL-6 was investigated to a further extent. Values 
represent mean +/- SEM. 
 
For all measurements, toxin dilutions were pre-incubated with polymyxin B in order 
to abolish an activation of TLR 4 by LPS. Cells that were treated with WT-PLY alone could 
show activations mediated by LPS and by the toxin. After pre-incubation with 30 µM 
polymyxin a possible activation of TLR 4 by LPS should be abolished. Pre-incubation with 
Cholesterol should inhibit any membrane binding and thus the pore-forming effect of 
PLY-WT. It becomes visible, that PLY-WT alone, after Polymyxin B pre-treatment, shows a 
higher activation of IL-6 compared to the untreated PLY-WT. After pre-treatment with 
Cholesterol the release of IL-6 is abandoned. 
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Fig 37: Treatment of primary mouse astrocytes with PLY-WT. Either cells were treated with PLY-WT and 
medium, with PLY-WT and 30 µM polymyxin B (PM) or with cholesterol (Chol.). Polymyxin B should abolish 
LPS from the toxin-dilution and thus only PLY-WT activation of IL-6 should be visible. Cholesterol should 
saturate the binding-site of PLY to membrane-cholesterol and thus only action by LPS should be visible. 
Values represent mean +/- SEM. 
 
IL-6 is increased after treatment with PLY-WT compared to control cells. The PLY-
variants show no increase. If the heat-killed S. pneumonia (HKSP) were added to the toxin 
treatment the production of IL-6 increased to a lesser extent (1.5-fold compared to the 
corresponding control. Again, the PLY-variants showed no increase. Furthermore, 
treatment with dynasore showed a smaller amount of IL-6 production, whereas 
treatment with blebbistatin led to a similar increase in IL-6 production compared to the 
treatment with PLY-WT alone. The fold-changes are shown in the appendix (Table 14). 
 
4 Results 
 
61 
 
 
Fig 38: Quantification of IL-6 after treatment with PLY-WT, PLY-∆6 and PLY-W433F either with or without 
HKSP. Toxin dilutions were pre-incubated with Polymyxin B in order to abolish an activation of IL-6 
production by LPS. Values represent mean +/- SEM. 
 
Furthermore, acute brain slices were incubated for 5 h with PLY-WT and with 
medium alone. The longer incubation time can be explained by the duration of the toxin 
needed in order to penetrate the tissue. In addition, the polymyxin B control was carried 
out as well. In Fig 39 it becomes visible that PLY-WT shows no significant LPS 
contamination. It is also visible that PLY-WT also leads to an increase in IL-6 production in 
acute brain slices and not only in the PMA monolayer. 
 
Fig 39: Treatment of acute brain slices from mice show an increase of IL-6 production compared to the 
control. Polymyxin B alone showed no increase of IL-6. 
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5 DISCUSSION 
5.1  Properties of pneumolysin-wildtype and pneumolysin-variants at 
the cell membrane and effects on the actin cytoskeleton 
Sections of this discuccion have been published in (Fortsch, Hupp et al. 2011) and in 
(Wippel, Fortsch et al. 2011). 
Previously, a small GTPase-dependent actin remodeling in SH-SY5Y neuroblastoma 
cells by wildtype pneumolysin (PLY-WT) at sub-lytic concentrations has been 
demonstrated (Iliev, Djannatian et al. 2007). In this work the role of pore-formation on 
these observations was investigated. To this end, variants of Pneumolysin, which are 
incapable of forming pores, have been investigated. Treatment with PLY-WT led to 
cellular displacement compared to the variants that did not cause these changes (Fig 26). 
Active cellular retraction and displacement in a given direction should be accompanied by 
changes in the focal adhesion formation and size (Shemesh, Verkhovsky et al. 2009). The 
cell accomplishes this by establishing traction points (Mierke 2009). Here, focal adhesions 
were visualized by immuncytochemical staining for Vinculin, a marker for focal adhesions. 
Cells were challenged with PLY-variants, which are described in 1.3.4 with PLY-WT, PLY-∆6 
and PLY-W433 (Fig 27). After treatment of cells with PLY-WT for 30 min, astrocytes 
seemed to form more and more definded focal adhesions. The cells showed more stress 
fibers compared to cells treated with PLY-∆6, PLY-W433F and medium only. This indicates 
a RhoA GTPase-like activation by PLY-WT, analogous to earlier experimental findings in 
neuroblastoma cells (Iliev, Djannatian et al. 2007). This shows that the cell shape changes 
represent active cytoskeleton reorganizing phenomena without a loss of surface 
attachment (Oliver, Lee et al. 1994). The presence of focal points in astrocytes under 
normal, untreated conditions indicated a capacity to be motile and thus to react to toxin 
stimulation with increased cell movement (Fortsch, Hupp et al. 2011). 
These observations confirm that active cytoskeleton reorganising events follow PLY-
WT challenge in primary astroglial cells, but not after challenge with non-pore forming 
variants. This finding supports the general idea that mammalian cellular motility depends 
on actin reorganisation phenomena reviewed by Pollard and Borisy (Pollard and Borisy 
2003), Ridley et al. (Ridley 2001) and Pollard and Cooper (Pollard and Cooper 2009). One 
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aim of this work was to investigate the role of the pore-forming capacity of PLY as an 
initiation factor for the occurring actin cytoskeletal reorganisation phenomena. Toxin-
induced actin-reorganising phenomena in glial cells seem to be more complex than those 
observed in human neuroblastoma cells and some non-small GTPase-dependent events 
might contribute to their occurrence.  
Furthermore, a dose-dependent cell lysis was observed. As PLY-WT is a cytolysin, it was 
necessary to define the terms lytic/sublytic/non-lytic concentrations precisely for the 
used system. Primary mouse astrocytes were challenged with PLY-WT in the presence of 
PI (propidium iodide), using PLY-WT concentrations in the range from 0.05 to 0.5 µg/ml 
(Fig 19) (Fortsch, Hupp et al. 2011). Simultaneous staining with PI allowed an exclusion of 
permeabilised for subsequent experiments. PI iodide staining has been shown to be 
suitable for a discrimination of acutely lytic cells from non-lytic cells (Darzynkiewicz, 
Bruno et al. 1992). In addition, “classical” PLY-WT membrane pores with a suggested size 
of 260 Å should be PI-permeable (MW 650) (Iliev, Djannatian et al. 2007). However, no 
firm evidence that PI can penetrate fast enough through individual macropores to stain 
the chromatin could be found. Moreover, the possibility of transient pores can not be 
excluded and as there is no guarantee that PI could enter the cell through transient pores. 
Thus, the definition of lytic (permeabilised) and non-lytic (non-permeabilised) cells was 
chosen (Fortsch, Hupp et al. 2011). In addition, the ability to cause cell-lysis was 
investigated by measuring the release of lactate-dehydrogenase (LDH). As can be seen in 
Fig 18, only the PLY-WT was able to cause cell-lysis. Here, a 10-fold higher toxin 
concentration, than found in meningitis, was used. The variants PLY-W433F and PLY-Δ6 
did not lead to cell lysis. This serves as one proof of the incapability of those variants to 
form pores. After challenge of primary mouse glial cells with physiological calcium 
concentrations (2 mM) and PLY-WT, the toxin showed a decreased toxic effect compared 
to the effect in medium deprived of calcium (Fig 33). Here, evidence for the dependence 
of the lytic capacity of PLY on the extracellular concentration of Ca2+ can be shown. 
Reduction of Ca2+-concentration may have profound effects on PLY-WT neurotoxicity 
enhancement. Reduction of Ca2+-concentration could transform sub-lytic 
pathophysiological concentrations into lytic concentrations, worsening the course of the 
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disease. Unfortunately, there is no systematic evidence for the dynamic changes of Ca2+-
concentration in the brain during the clinical course of pneumococcal meningitis. 
The necessity of lytic pore formation for actin-dependent effects could be excluded, it 
remained unclear whether pore formation is needed at all or not. Evidence exists that 
PLY-WT builds a heterogenous population of pores, many of which have ion channel 
properties (Vikman, Backstrom et al. 2001). In these experiments, PLY-WT concentrations 
exceed physiological concentrations found in meningitis by a factor of 10 or more. In 
meningitis, values up to 0.2 µg per ml CSF were found (Spreer, Kerstan et al. 2003), while 
PLY-WT and non-pore forming variants (Korchev, Bashford et al. 1998; Kirkham, Kerr et al. 
2006) were applied at concentrations up to 10 µg per ml in the experiments. In this work 
toxins were used in concentrations within the disease-relevant range (up to 0.2 µg/ml). 
Both mutants bound to the cell membranes in a manner similar to PLY-WT (Fig 20). This 
was further confirmed by biochemical spectrophotometric cholesterol-binding 
experiments by scanning for tryptophan-fluorescence (Fig 23). The binding capacity 
however, differed among the pneumolysin variants, therefore the concentration of the 
mutants was adjusted in all further experiments to fit exactly the PLY-WT binding. As 
expected, none of the mutants was lytic in the range of 0.1 to 0.5 µg/ml (Fig 18). Earlier 
experiments in artificial membranes and cell membrane patches show that PLY-W433F 
form big (presumably lytic) pores at concentrations of 5 µg/ml and more (Vikman, 
Backstrom et al. 2001; El-Rachkidy, Davies et al. 2008). They exceed, however, many 
times the physiological concentration of PLY in meningitis.  
In primary glial culture in non-lytic conditions PLY-WT induced membrane 
depolarization Fig 22). Membrane polarity was analysed by using the oxonol dye DiBAC4. 
This dye does not cause mitochondrial uncoupling and shows a linear fluorescence versus 
membrane penetration relationship (Epps, Wolfe et al. 1994). The fluorescence-emission 
of the dye increases when interacting with intracellular proteins, preferably with 
hydrophobic binding sites. Since PLY-WT pores are known to be predominantly cation-
conductive (Korchev, Bashford et al. 1998; Vikman, Backstrom et al. 2001; El-Rachkidy, 
Davies et al. 2008), the occurrence of membrane depolarisation implies a role of sodium 
and/or calcium influx. However, it cannot be excluded that membrane depolarisation is 
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not related to direct effects of the PLY pores, but due to the involvement of endogenous 
ion channels as suggested previously (Iliev, Djannatian et al. 2007).  
Consistent with the depolarisation experiments, the conductance of PLY-WT, PLY-
W433F and PLY-Δ6 in planar lipid bilayer (PLB) as previously described was tested (Benz, 
Janko et al. 1978). In order to achieve an accelerated pore-formation, small amounts of 
oxidised cholesterol (about 30 % v/v) were added to the planar lipid bilayer. This is a well-
known approach (Benz, Janko et al. 1978), but the exact molecular steps involved in 
improving the pore formation remain unclear. It is known, however, that the oxidised 
cholesterol dramatically improves both the elastic properties of artificial membranes 
(Benz, Beckers et al. 1979) and membrane fluidity (Wood, Igbavboa et al. 1995). Here, 
only PLY-WT was capable of forming big pores, most likely corresponding to lytic pores 
(Fig 24, arrow). Smaller oscillations (up to 25 pA) were also observed, showing an activity 
at the artificial membrane. Small conductance oscillations (not bigger than 5 pA) were 
seen with the PLY-W433F, although much smaller and infrequent than with PLY-WT at an 
equivalent toxin concentration. PLY-Δ6 did not lead to any conductance changes, i.e. no 
pore-forming capacity was present. Micropores caused by PLY-W433F as defined before 
(Vikman, Backstrom et al. 2001) could not be found, which may be due to the much lower 
toxin concentrations used and the presence of cholesterol in the PLB.  
In artificial bilayer, the change in Ca2+-concentrations did not affect the size or 
properties of individual PLY pores (Fig 25). The lack of effect of Ca2+ on ion conductance 
was surprising, because other studies have indicated the gating sensitivity of cation-
selective PLY pores at higher-than-physiological bivalent ion concentrations (1–5 mM Zn2+ 
and 10–20 mM Ca2+). This suggests that pore characteristics may be modulated by 
divalent cations (Vikman, Backstrom et al. 2001). Thus, it is possible that the enhanced 
binding of PLY-WT to membranes at low Ca2+-conditions involves a similar change in 
membrane fluidity.  
The ion selectivity of PLY micropores, derived from experiments with the PLB, indicates 
relative cation selectivity and sensitivity against closure by bivalent ions such as calcium 
(Ca2+) and zink (“small” pores). PLY-WT alone is a factor, known to produce an increase in 
cellular Ca2+ (Stringaris, Geisenhainer et al. 2002), thus Ca2+-selective micropores should 
be additionally considered, assuming that they exist and play a role in plasma Ca2+-
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elevation. Local increase of cytosolic Ca2+ contributes to cellular motility in electrical field 
stimulation model systems, which partially resembles the effects of PLY on membrane 
electrical phenomena (Onuma and Hui 1988; Ozkucur, Monsees et al. 2009). The major 
source of Ca2+-influx into cells after PLY challenge is the extracellular environment 
(Stringaris, Geisenhainer et al. 2002), although Ca2+-influx from intracellular stores, the 
biggest of which is the endoplasmic reticulum (ER) (Reyes and Parpura 2009), should also 
be considered.  
Furthermore, it has been shown that the activation of Rac1 by PLY-WT in the human 
neuroblastoma cell SH-SY5Y is Ca2+-influx-dependent (Iliev, Djannatian et al. 2007). This 
experimental setup, however, excludes the role of intracellular Ca2+-depots, thus making 
it difficult to estimate the role of Ca2+-influx for the initiation of cell shape changes. To 
answer the question about the initiating role of Ca2+-influx in PLY-WT induced cell shape 
changes, the role of PLY-WT on astrocytes in Ca2+-free medium was tested. LDH-release 
showed a higher toxicity of PLY-WT after depletion of extracellular Calcium (Fig 33) 
indicating a possible protective function of calcium on cells against PLY challenge.  
This work provides evidence for the critical importance of the PLY pore forming 
capacity in cell shape changes. The mechanistic role of membrane depolarisation and 
Ca2+-influx as pore-related cell shape change initiation factors can yet not be explained 
eintirely. However, the modulatory role in the cellular motility effects following the initial 
PLY challenge cannot be excluded. The possibility that other pore formation-related 
factors also play a role of the actin cytoskeleton effects of PLY exists. One of those is the 
interaction with plasmalemmal molecules or with molecules, positioned immediately 
under the membrane. This could play a role in cellular transport mechanisms which 
interactions would require the toxin molecules to be in a folded pore-like conformational 
state in order to interact, thus explaining the need of pore-forming capacity. 
Although many bacterial toxin possess the feature of modulating actin cytoskeleton 
dynamics, mostly via small GTPase activation or inhibition (Aktories and Barbieri 2005), 
only few of these toxins possesses pore forming capacity. Our finding of small GTPase 
activation via PLY in human neuroblastoma cells (Iliev, Djannatian et al. 2007) suggests a 
possible role not only of pore formation, but of cholesterol sequestration and others. The 
pore forming capacity remains essential for the rapid cytoskeletal reorganization, 
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implying that PLY pore formation might play a much more complex role in the modulation 
of pathogen virulence than thought before. 
 
5.2 From membrane to cellular trafficking 
As observed, the PLY-WT, but not the non pore-forming variants, were internalised 
into the cell (Fig 34). The question remained, which mechanisms are involved and what 
the impact on the cell would be. Obviously, the interaction of the toxin with the 
membrane will involve not only the initial binding but also the following steps. As the 
membrane binding did not seem to have an effect on membrane depolarisation, 
discussed in the previous section, it could be assumed that the following observed effects 
would be due to an internalisation and not due to membrane binding or pore-formation.  
Internalisation of a pore-forming toxin can have several alternative implications:  
1.) cell protection, 2.) increased pathogenic response by internalisation of toxic 
components; 3.) improved transcytosis and 4.) artefacts. 
To clarify these implications, the question of compartmentalisation and whether 
this compartment is the same as the ones that were enhanced by PLY-WT in the FM 1-43 
assays, needed to be studied. The co-challenge of cells with inhibitors for myosin II and 
for dynamin prior to toxin challenge, led to a further discrimination which endocytotic 
pathway could be influenced by the toxin. Blebbistatin is known to be a specific inhibitor 
for non-muscle myosin II (Kovacs, Toth et al. 2004). Furthermore, myosin II plays a role in 
endocytotic processes e.g. fluid phase endocytosis. Here, the mechanism is regulated via 
the guanine exchange factor RhoGEF2 and thus is linked to actin cytoskeleton (Levayer, 
Pelissier-Monier et al. 2011). Dynamin plays an essential role e.g in clathrin-coated vesicle 
formation during endocytosis and thus is an important regulatory GTPase in endocytosis 
(Gu, Yaddanapudi et al. 2010). After blocking the cells with dynasore, inhibiting dynamin, 
and with inhibitors for dynamin and myosin II together, the rate of endocytosis after PLY 
challenge was blocked to a control level in live cell imaging.  
FM 1-43 serves as a marker of overall endocytosis. It inserts into the outer leaflet of the 
membrane and gains its fluorescence properties in a hydrophobic milieu (Vida and Emr 
1995; Murthy and Stevens 1998; Brumback, Lieber et al. 2004). Furthermore, it could be 
shown, that FM 1-43 follows a classical endocytic pathway as the increase in fluorescence 
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could not be observed after inhibition of endosomal acidification with Bafilomycin (Fig 
28). The internalisation of FM 1-43 is inhibited by dynasore. This observation is consistent 
with the current knowledge on classical endosomes, namely where Dynamin plays a 
crucial part in the internalisation of classical endosomes. However, the inhibition of 
myosin II led to an increased overall uptake of FM 1-43 positive vesicles, whereas the 
internalisation on PLY-GFP seemed to be decreased (Fig 34). It is possible that these two 
different internalisation phenomena, FM 1-43- and PLY-GFP-internalisation, were 
uncoupled. Furthermore, these observations could mean that PLY is internalised in a 
dynamin and myosin II independent manner and thus caveolin- and clathrin dependent 
mechanisms can be ruled out (Fig 10).  
Classical endocytotic pathways could be ruled out via immunocytochemical staining 
for different compartmental markers. The internalisation of albumin indicates a caveolin 
dependent endocytosis (Bento-Abreu, Velasco et al. 2009), transferrin a clathrin 
dependent endocytosis (Pearse and Robinson 1990) and dextran indicates phagocytosis 
(Costantini, Gilberti et al. 2011; Levayer, Pelissier-Monier et al. 2011). Internalised PLY-
GFP showed no co-localisation with the used endocytic markers. Thus, the proposed 
mechanism of internalisation is most probably dynamin- and caveolin-independent 
pinocytosis leading the toxin to caveosomes. These caveosomes avoid the endosomes 
and lysosomes, so that the destination of the caveosome within the cell is not yet clear 
(Alberts 2008). This information suggests that the protein would not be degraded within 
the cell. The observation of an increased rate of endocytosis after toxin challenge might 
argue for a strategy of the cell to defend itself against the formation of micro- or macro-
pores and thus avoid bacterial invasion. It has also been shown that cells use endo- and 
exocytosis as a strategy to eliminate pore-forming toxins from the cell surface (Husmann, 
Beckmann et al. 2009) in order to achieve a repair of the plasma membrane (Los, Kao et 
al. 2011). Previously, it has been shown, that bacterial protein toxins are internalised via 
different endocytotic pathways in order to enable bacteria to invade the cell (Lin and 
Guttman 2010). Exemplary the anthrax toxin binds to its receptor and upon 
oligomerisation is internalised via clathrin-dependent endocytosis. Upon acidification of 
the endosomes, a pore is formed in the endosomes releasing toxic factors into the cytosol 
(Young and Collier 2007). However, it has to be mentioned that the visible clusters of PLY-
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GFP, which were detected by the microscopy used in this work, do not necessarily 
represent the entire pool of toxin used. It is possible that a small fraction, which would 
not be detecteable by methods used, is internalised in a dynamin- or blebbistatin-
dependent mechanism. Such a concept would be supported by the experiments carried 
out with the dye DiBAC4. If pneumolysin forms pores or micropores at the membrane, the 
membrane potential would change and the dye could enter the cytosol (Epps, Wolfe et al. 
1994). As the treatment of cells with dynasore and both inhibitors showed a decrease of 
overall endocytosis (Fig 30), these micropores could stay for a longer time on the cell 
surface and thus lead to a higher degree of depolarisation compared to cells treated with 
blebbistatin alone. Here, the overall rate of endocytosis increased, thus internalising 
possible micropores more quickly and leading to a decrease in membrane depolarisation 
compared to samples, where no inhibitor was used. Another explanation would be that 
the cell increases the effort on other endocytic processes in order to compensate for the 
loss of the inhibited endocytic mechanisms. One question is, if the cell defends itself via 
these mechanisms, or if the bacteria also utilise pinocytic processes in order to invade 
into the cell or further tissue. 
If injury is caused at the cell membrane, the cell uses repair-mechanisms, which are 
managed via endo- and exocytosis (Alberts 2008). Previously, it has been shown that 
sequential endocytosis and exocytosis serve as a mechanism to eliminate pore-forming 
(e.g. α-toxin from S. aureus) toxins from the cell without degrading them (Husmann, 
Beckmann et al. 2009). Furthermore, a dependency of these exocytotic repair 
mechanisms on calcium has been described (Bi, Alderton et al. 1995; Tam, Idone et al. 
2010). 
As previously mentioned, the lytic capacity of the PLY-WT has been tested under 
different calcium conditions (Fig 32). The absence of calcium, which is known to block 
large portions of endocytosis, showed a higher lytic capacity of PLY-WT compared to the 
physiological presence of 2 mM calcium. Contrary to other toxins the presence of calcium 
did not increase (Gekara, Westphal et al. 2007; Idone, Tam et al. 2008), but even decrease 
the rate of PLY-dependent endocytosis in FM 1-43 live-imaging (Fig 33). Again, in the 
description of exocytotic repair mechanisms calcium seems to have a crucial role. The 
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toxin has a far more toxic effect in calcium-free conditions than is has when extracellular 
calcium is available.  
 
5.3 PLY and innate immunity 
In the previous section, the internalisation of PLY-WT was discussed. The second, 
much more system-relevant question is why a bacterial toxin is internalised in a “non-
classical” endocytotic manner and what the aim of the toxin-induced enhancement might 
be. Are the observed effects artefacts or a strategy of the cell to react to the toxin-
stressor at the membrane? It has been shown previously that S. pneumoniae induces 
increased levels of TNF-α, IL-1β and IL-6 in rat brain, in the hippocampal formation and 
the prefrontal cortex, after meningitis (Dessing, Hirst et al. 2009; Barichello, dos Santos et 
al. 2010) and can initiate innate immune reactions, like TLR 2 and TLR 4-dependent 
responses (Paterson and Mitchell 2006). Furthermore, it has been discussed, whether PLY 
itself is recognised by TLR4 and thus leads to a direct activation of a TLR4-dependent 
answer (Weclewicz, Kristensson et al. 1994; Srivastava, Henneke et al. 2005; Paterson and 
Mitchell 2006; Marriott, Mitchell et al. 2008; Dogan, Zhang et al. 2011) or whether 
stimulation of the innate immunity is mediated by the action of stress kinases, such as 
MAPK, or oxidative stress caused by the complement system (Stringaris, Geisenhainer et 
al. 2002; Dessing, Hirst et al. 2009; Barichello, dos Santos et al. 2010; McNeela, Burke et 
al. 2010). Thus, another question that remained was, whether the cells would react to this 
possible stressor with a proinflammatory response.  
Due to the observed endocytotic processes the original hypothesis was that the 
enhanced cellular trafficking can be linked to the signalling of the TLR 2 and 4. This led to 
the investigation of four proinflammatory cytokines (IL-1β, IL-6, IL-12(p40) and TNF-α ) as 
shown in Fig 12. 
In this work, the production of IL-1β, IL-12 and TNF-α was not increased. This 
contradicts the described findings from the previously described research. 
Only IL-6 levels were elevated after treatment with PLY-WT (Fig 38). IL-6 serves as a key 
player in the production of acute phase proteins. Furthermore, it mediates T-cell 
activation, growth and differentiation (Borish and Steinke 2003). The production of no 
other proinflammatory cytokine was increased (Fig 36). 
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The non pore-forming variants, although they all bound to the membrane and did 
not lead to an increase in endocytotic rate, did not lead to a production of the 
pro-inflammatory cytokine IL-6. This led to the question, if the internalisation or the pore-
forming capacity of the toxin would be the activating factor.  
Since many of the TLR receptors require endocytotic events (Blasius and Beutler 
2010) to achieve activation, the production of inflammatory cytokines upon PLY-WT 
treatment in combination with inhibitors for dynamin and myosin II was analysed. The 
inhibition of dynamin and myosin II did not affect the production of IL-6. This shows that 
the activation of IL-6 production is independent of dynamin and myosin II dependent 
endocytotic processes. A possible explanation for the raised levels of IL-6 could be that 
WT-PLY directly activates TLR 4, as reported previously (Weclewicz, Kristensson et al. 
1994) (Dessing, Hirst et al. 2009) and thus leads to the IL-6 production (Lehnardt 2010; 
McGettrick and O'Neill 2010). Furthermore, an activation of TLR 4 by WT-PLY has been 
discussed (Dogan, Zhang et al. 2011).  
Due to the lack of elevation of IL-6 after treatment with the PLY-Δ6 and PLY-W433F 
another possibility would be that the pore-forming capacity would be required for this 
activation. 
In order to eliminate any possibility for off-target activation of TLR 4 via LPS, all 
toxin dilutions were pre-incubated with Polymyxin B. The toxins were expressed in E. coli 
and purified from this Gram negative bacterium, which could lead to small LPS traces 
despite thorough sample cleaning that would lead to an activation of TLR 4. Polymyxin B 
is supposed to eliminate most of the remaining LPS (Cardoso, Araujo et al. 2007). The 
pre-treatment of toxin dilutions with Polymyxin B, however, showed no difference in the 
production of the observed proinflammatory cytokines. Again, only IL-6 was elevated to 
the same extend as in treatment without Polymyxin B. 
Another explanation for the raise of proinflammatory cytokines could be the 
activation of TLR 2 via peptidoglycane. For tackling this question, heat killed S. 
pneumoniae (HKSP) was added to the toxin dilutions. Fig 38 shows that again only the 
PLY-WT in combination with HKSP leads to an increased production of IL-6 in contrast to 
the variants, where no raise could be observed. However, the increase was lower 
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compared to treatment without HKSP. Thus, the effects observed can only be caused by 
PLY-WT and no co-stimulation by LPS or peptidoglycan would be necessary. 
The discrepancy between the presented experiments and the data about 
inflammatory cytokine upregulation by PLY-WT can have several explanations. In studies 
described in literature, mice were treated either by nasopharyngeal injection (Dessing, 
Hirst et al. 2009; McNeela, Burke et al. 2010) with S. pneumoniae or with a direct 
injection into the 3rd ventricle (Barichello, dos Santos et al. 2010) of the brain. Overall 
infection with the Streptococcus ranged from 12-24 h and more. In the experiments 
shown in this work, astrocytes grown in the monolayer were treated with PLY-WT for 90 
min. Following this incubation, the medium of cells was completely changed to complete 
medium and cells were left to rest for 21 h. The aim was to reduce the delayed apoptotic 
toxicity which was observed with PLY-WT after continuous incubation (Stringaris, 
Geisenhainer et al. 2002) to a minimum. Apoptotic cells could lead to a non-specific glial 
response like astrocytic reactive gliosis (Barreto, Gonzalez et al. 2011) and this could be 
the reason for the discrepancy between the findings of this work and the findings from 
previous papers that demonstrate an increase of IL-1β, TNF-α and others. Additionally, 
astrocytes represent the major source of IL-6 in CNS injury and neuroinflammation (Ma, 
Reynolds et al. 2010). 
One can argue that this increase in proinflammatory cytokine IL-6 could lead to a 
clearance of the pathogen from the infected tissue. Previously, it has been discussed 
whether this proinflammatory response has a supporting or a damaging function in 
neurological disorders (Wee Yong 2010) and if the production of proinflammatory 
cytokines (e.g. IL-6) leads to neurodegeneration or neuroprotection (Lehnardt 2010). 
In bacterial meningitis, the gene expression of the TLRs is upregulated and animals 
deprived of either TLR 2 or TLR 4 show a worsened course of infection with 
S. pneumoniae (Chin, Ifversen et al. 1994; Gerber and Nau 2010). Furthermore, an 
anti-inflammatory treatment in experimental bacterial meningitis caused a milder course 
of disease (Zysk, Bruck et al. 1996) and the inflammatory response by astrocytes or 
microglia might have a neurotoxic effect (Lehnardt 2010), which would enable bacteria to 
invade deeper into the brain. Here, neuroinflammation would lead to a worsened course 
of disease. 
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On the other hand it has been discussed that an inflammation of neural cells will 
lead to apoptosis, and thus serve as a mechanism of protection from invasive diseases 
(Srivastava, Henneke et al. 2005), neuroinflammation (Lehnardt, Massillon et al. 2003; 
McNeela, Burke et al. 2010) and neurodegeneration for example in multiple sclerosis or 
experimental allergic encephalomyelitis (Suzumura, Takeuchi et al. 2006). 
Additionally, it has been shown that neuroinflammation could lead to an increased 
proliferation of neural cells in meningitis (Gerber, Bottcher et al. 2003; Gerber, Tauber et 
al. 2009). Thus, the question whether this inflammation serves as a support for bacteria 
to enhance invasion or as a defense of the cell against these pathogens remains open. 
 
After Pneumolysin challenge primary mouse astrocytes showed changes compared to 
the variants and untreated control cells. Only the wildtype causes membrane 
depolarisation, pore-formation, membrane binding and cytoskeletal changes. This data 
shows that the pore-formation is critically important. The depolarisation seems to be 
secondary and not essential for cytoskeletal changes. The toxin only produces lysis on the 
cell surface leading to the idea that the internalisation could serve as a protective 
mechanism of the cell or establish the toxic function of pneumolysin. Apart from cell-lysis 
or shape-changes PLY-challenge could lead to the activation of TLR 2 and 4. Since TLR 
signalling can require endocytosis, the effect of pneumolysin on pro-inflammatory was 
thought to be linked to endocytotic events. Surprisingly, only IL-6 showed an increase 
compared to previous studies showing an influence of PLY on TNF-α and IL-1β. 
Additionally, this increase seemed to be independent of endocytosis. Furthermore, this 
work shows that neuroinflammatory responses are not directly linked to endocytotic 
events. 
Future work should further investigate the exact role of PLY on downstream TLR and 
IL-6 signaling as well as the meaning of this IL-6 elevation on the course of meningitis. 
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8 APPENDIX 
8.1 Fold changes of IL-6 
Table 14: Fold-changes of IL-6 production after Toxin challenge. Raises in IL-6 are either compared to the 
corresponding control or to the control of treated cells without HKSP. 
 values normalised 
(CTRL corresponding) 
values normalised  
(CTRL without HKSP) 
PLY n.i. 2,06 
1,35 
1,88 
0,85 
0,78 
0,99 
0,93 
0,94 
0,92 
PLY D 
PLY B 
∆6 n.i. 
∆6 D 
∆6 B 
W433F n.i. 
W433F D 
W433F B 
PLY n.i. HKSP 1,50 1,34 
PLY D HKSP 1,48 1,15 
PLY B HKSP 1,47 1,87 
∆6 n.i. HKSP 0,92 0,83 
∆6 D HKSP 0,92 0,71 
∆6 B HKSP 0,80 1,02 
W433F n.i. HKSP 0,85 0,76 
W433F D HKSP 1,03 0,80 
W433F B HKSP 0,83 1,06 
CTRL HKSP n.i. - 0,89 
CTRL HKSP D - 0,78 
CTRL HKSP B - 1,27 
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8.2 Protein ladders 
 
       
 
 
 
